Document:

EX-4.2

 Exhibit 4.2 

PROCORE TECHNOLOGIES, INC. 

SIXTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

THIS SIXTH AMENDED AND RESTATED INVESTOR
RIGHTS AGREEMENT (the “Agreement”) is entered into as of September 24, 2019, by and among PROCORE TECHNOLOGIES,
INC., a Delaware corporation (the “Company”) and the investors listed on EXHIBIT A hereto, referred to hereinafter as the
“Investors” and each individually as an “Investor.” 
 RECITALS 

A.    Certain of the Investors are holders of the Company’s Series A Convertible Preferred Stock (the
“Series A Preferred Stock”), Series B Convertible Preferred Stock (the “Series B Preferred Stock”), Series C Convertible Preferred Stock (the “Series C Preferred Stock”), Series
D Convertible Preferred Stock (the “Series D Preferred Stock”), Series E Convertible Preferred Stock (the “Series E Preferred Stock”), Series F Convertible Preferred Stock (the “Series F
Preferred Stock”), Series G Convertible Preferred Stock (the “Series G Preferred Stock”), Series H Convertible Preferred Stock (the “Series H Preferred Stock”) and Series H-1 Convertible Preferred Stock (the “Series H-1 Preferred Stock” which, together with the Series A Preferred Stock, the Series B Preferred Stock, the
Series C Preferred Stock, the Series D Preferred Stock, the Series E Preferred Stock, the Series F Preferred Stock the Series G Preferred Stock and the Series H Preferred Stock shall be referred to herein collectively as the “Existing
Preferred Stock”) and are parties to the Fifth Amended and Restated Investor Rights Agreement dated as of July 30, 2019 (the “Prior Agreement”). 

B.    Certain of the Investors are purchasing shares of the Company’s Series I Convertible Preferred Stock
(the “Series I Preferred Stock” which, together with the Existing Preferred Stock shall be referred to herein collectively as the “Preferred Stock”) pursuant to that certain Series I Convertible
Preferred Stock Purchase Agreement (the “Purchase Agreement”) of even date herewith (the “Financing”). 

C.    Certain obligations in the Purchase Agreement are conditioned upon the execution
and delivery of this Agreement. 
 D.    In connection with the consummation of the Financing, the parties hereto
desire to enter into this Agreement in order (a) amend and restate the Prior Agreement in its entirety as set forth herein and (b) to grant the registration rights, information rights, and other rights to the Investors as set forth below.

 AGREEMENT 

NOW, THEREFORE, in consideration of these premises and for other good and valid
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
  

	1.	 GENERAL. 

1.1    Definitions. As used in this Agreement the following terms shall have the following respective meanings: 

(a)    “Acquisition” shall have the meaning given such term in the Certificate. 

  
 1 

 (b)    “affiliate” means, with respect to
any Person, any other Person who or which, directly or indirectly, controls, is controlled by, or is under common control with such specified Person, including, without limitation, any general partner, officer, director or managing member of such
Person and any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members of, or is under common investment management with, such Person. 

(c)    “Board” means the Board of Directors of the Company. 

(d)    “Certificate” means the Certificate of Incorporation of the Company, as amended or
amended and restated from time-to-time. 

(e)    “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

(f)    “Form S-3” means
such form under the Securities Act as in effect on the date hereof or any successor or similar registration form under the Securities Act subsequently adopted by the SEC which permits inclusion or incorporation of substantial information by
reference to other documents filed by the Company with the SEC. 
 (g)    “Founders”
shall mean Craig F. Courtemanche, Jr. and Steven C. Zahm. 
 (h)    “Holder” means any
person owning of record Registrable Securities that have not been sold to the public or any assignee of record of such Registrable Securities in accordance with Section 2.10 hereof. 

(i)    “Initial Offering” means the Company’s first firm commitment underwritten
public offering of its Common Stock registered under the Securities Act. 
 (j)    “Institutional
Majority” means the holders of a majority of either (i) the Series D Registrable Securities then outstanding or (ii) the Series E Registrable Securities then outstanding. 

(k)    “Major Investor” means (i) any Investor that holds
at least 2,900,000 shares of Preferred Stock (as adjusted for any stock dividends, combinations, splits, recapitalizations and the like after the date hereof), and (ii) Tiger, as long as Tiger and its affiliates hold at least 2,900,000
Registrable Securities (as adjusted for any stock dividends, combinations, splits, recapitalizations and the like affecting such shares after the date hereof). Notwithstanding the foregoing, no holder of Series
H-1 Preferred Stock shall be deemed a Major Investor under the terms of this Agreement. 

(l)    “Person” means any individual, corporation, partnership,
trust, limited liability company, association or other entity. 
 (m)    “Qualified Public
Offering” shall have the meaning given such term in the Certificate. 

(n)    “Register,” “registered,” and
“registration” refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act, and the declaration or ordering of effectiveness of such registration statement or
document. 
 (o)    “Registrable Securities” means (i) Common Stock of the Company
issuable or issued upon conversion of the Shares, (ii) any Common Stock, or any Common Stock issuable or issued (directly or indirectly) upon conversion and/or exercise of any other security of the Company, acquired by any Investor on or after
January 1, 2019 and (iii) any Common Stock of the Company issued as (or 

  
 2 

 
issuable upon the conversion or exercise of any warrant, right or other security which is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of,
such above-described securities in clauses (i) and (ii). Notwithstanding the foregoing, Registrable Securities shall not include any securities (A) sold by a person to the public either pursuant to a registration statement or Rule 144, (B)
sold in a private transaction in which the transferor’s rights under Section 2 of this Agreement are not assigned, or (C) held by a Holder (together with its affiliates) if the Company has completed its Initial Offering and all shares
of Common Stock of the Company issuable or issued upon conversion of the Shares held by and issuable to such Holder (and its affiliates) may be sold pursuant to Rule 144 without limitation during any ninety (90) day period without registration.

 (p)    “Registrable Securities then outstanding” shall be
the number of shares of the Company’s Common Stock that are Registrable Securities and either (i) are then issued and outstanding or (ii) are issuable pursuant to then exercisable or convertible securities. 

(q)    “Registration Expenses” shall mean all expenses incurred by the Company in complying
with Sections 2.2, 2.3 and 2.4 hereof, including, without limitation, all registration and filing fees, printing expenses, fees and disbursements of counsel for the Company, reasonable fees and disbursements not to exceed fifty thousand dollars
($50,000) of a single special counsel for the Holders, blue sky fees and expenses and the expense of any special audits incident to or required by any such registration (but excluding the compensation of regular employees of the Company which shall
be paid in any event by the Company). 
 (r)    “Requisite Senior Preferred Majority”
shall mean the holders of: (i) a majority of the Series D Registrable Securities then outstanding and (ii) a majority of the Series E Registrable Securities then outstanding, each voting as a separate class. 

(s)    “Right of First Refusal and Co-Sale
Agreement” shall mean the Sixth Amended and Restated Right of First Refusal and Co-Sale Agreement, dated as of the date hereof, by and among the Company and other parties thereto. 

(t)    “SEC” or “Commission” means the Securities and Exchange
Commission. 
 (u)    “Securities Act” shall mean the Securities Act of 1933, as amended.

 (v)    “Selling Expenses” shall mean all underwriting discounts and selling
commissions applicable to the sale of Registrable Securities and, except as set forth in the definition of “Registration Expenses” above, all fees and reimbursement of one counsel for the Holders. 

(w)     “Senior Preferred Registrable Securities” means the Series D
Registrable Securities, the Series E Registrable Securities, the Series F Registrable Securities, the Series G Registrable Securities, the Series H Registrable Securities and the Series I Registrable Securities. 

(x)    “Series D Designee” shall have the meaning given such term in the Voting Agreement.

 (y)    “Series D Registrable Securities” means the Registrable Securities issuable or
issued upon conversion of the shares of Series D Preferred Stock. 
 (z)    “Series E Registrable
Securities” means the Registrable Securities issuable or issued upon conversion of the shares of Series E Preferred Stock. 

  
 3 

 (aa)    “Series F Designee” shall have
the meaning given such term in the Voting Agreement. 
 (bb)     “Series F Registrable
Securities” means the Registrable Securities issuable or issued upon conversion of the shares of Series F Preferred Stock. 

(cc)     “Series G Registrable Securities” means the Registrable Securities
issuable or issued upon conversion of the shares of Series G Preferred Stock. 
 (dd)    
“Series H Registrable Securities” means the Registrable Securities issuable or issued upon conversion of the shares of Series H Preferred Stock. 

(ee)     “Series I Registrable Securities” means the Registrable Securities
issuable or issued upon conversion of the shares of Series I Preferred Stock. 
 (ff)    “Series D
Registrable Securities then outstanding” shall be the number of shares of the Company’s Common Stock that are Series D Registrable Securities and either (i) are then issued and outstanding or (ii) are issuable
pursuant to then exercisable or convertible securities. 
 (gg)     “Series E
Registrable Securities then outstanding” shall be the number of shares of the Company’s Common Stock that are Series E Registrable Securities and either (i) are then issued and outstanding or (ii) are issuable
pursuant to then exercisable or convertible securities. 
 (hh)     “Series F
Registrable Securities then outstanding” shall be the number of shares of the Company’s Common Stock that are Series F Registrable Securities and either (i) are then issued and outstanding or (ii) are issuable
pursuant to then exercisable or convertible securities. 
 (ii)    “Series G Registrable Securities
then outstanding” shall be the number of shares of the Company’s Common Stock that are Series G Registrable Securities and either (i) are then issued and outstanding or (ii) are issuable pursuant to then exercisable
or convertible securities. 
 (jj)    “Series H Registrable Securities then outstanding”
shall be the number of shares of the Company’s Common Stock that are Series H Registrable Securities and either (i) are then issued and outstanding or (ii) are issuable pursuant to then exercisable or convertible securities. 

(kk)     “Series I Registrable Securities then outstanding” shall be the
number of shares of the Company’s Common Stock that are Series I Registrable Securities and either (i) are then issued and outstanding or (ii) are issuable pursuant to then exercisable or convertible securities. 

(ll)    “Shares” shall mean the shares of Preferred Stock held from time to time by the
Investors listed on EXHIBIT A hereto and such Investors’ permitted assigns. 
 (mm)
“Special Registration Statement” shall mean (i) a registration statement relating to any employee benefit plan or (ii) a registration statement related to any corporate reorganization or transaction under Rule
145 of the Securities Act, including any registration statements related to the issuance or resale of securities issued in such a transaction or (iii) a registration statement related to the offer and sale of debt securities or the stock
issuable upon conversion thereof. 
 (nn)     “Subsidiary” means any direct
or indirect subsidiary of the Company now existing or formed hereafter (if any). 

  
 4 

 (oo)    “Tiger” means TIGER GLOBAL PIP 11
LLC and its affiliates. 
 (pp)    “Voting Agreement” shall mean the Sixth Amended and
Restated Voting Agreement, dated as of the date hereof, by and among the Company and other parties thereto. 
  

	2.	 REGISTRATION; RESTRICTIONS ON TRANSFER. 

2.1    Restrictions on Transfer. 

(a)    Each Holder agrees not to make any disposition of all or any portion of the Shares or Registrable Securities
unless and until: 
 (i)    there is then in effect a registration statement under the Securities Act covering
such proposed disposition and such disposition is made in accordance with such registration statement; or 

(ii)    (A) the transferee has agreed in writing to be bound by the terms of this Agreement, (B) such Holder
shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and (C) if reasonably requested by the Company, such Holder
shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration of such shares under the Securities Act. It is agreed that the Company will not require opinions
of counsel for transactions made pursuant to Rule 144, except in unusual circumstances. After its Initial Offering, the Company will not require any transferee pursuant to Rule 144 to be bound by the terms of this Agreement if the shares so
transferred do not remain Registrable Securities hereunder following such transfer. 
 (b)    Notwithstanding the
provisions of subsection (a) above, no such restriction shall apply to a transfer without consideration by a Holder: 

(i)    With respect to a Holder that is an entity, to any transfer by such Holder that is (A) a partnership
transferring to its partners or former partners in accordance with partnership interests, (B) a corporation transferring to a wholly-owned subsidiary or its stockholders in accordance with their ownership interest, (C) a limited liability
company transferring to its members or former members in accordance with their interest in the limited liability company, (D) a venture capital fund transferring to an investment fund now or hereafter existing that is controlled by one or more
general partners or managing members of, or shares the same management company with, such venture capital fund or a venture capital fund making distributions, (E) a trust transferring to a trust or beneficiary of the trust without
consideration, or (F) an entity transferring to an immediate family member of the persons controlling such entity without consideration; and 

(ii)    With respect to a Holder that is an individual, any transfer by such Holder without consideration to
(A) such Holder’s ancestors, descendants, siblings, spouse or in-laws (each, an “immediate family member”) or to trusts for the benefit of such persons or the Holder or to a company or
another entity wholly-owned by such Holder or any such person, or (B) by devise or descent; 

(iii)    provided that in each case the transferee will agree in writing to be subject to the terms and conditions
of this Agreement to the same extent as if such transferee were an original Holder hereunder. In addition, no Holder shall transfer any Shares to (y) any person whom the Company reasonably determines to be a competitor or strategic investor or
(z) any customer, distributor or supplier of the Company, if the Company should determine that such transfer would result in such customer, distributor or supplier receiving information that would place the Company at a competitive disadvantage
with respect to such customer, distributor or supplier. 

  
 5 

 (c)    Each certificate representing Shares or Registrable
Securities shall be stamped or otherwise imprinted with legends substantially similar to the following (in addition to any legend required under applicable state securities laws): 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”) AND MAY NOT BE
OFFERED, SOLD OR OTHERWISE TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT
REQUIRED. 
 THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND
CONDITIONS OF A CERTAIN INVESTOR RIGHTS AGREEMENT BY AND BETWEEN THE STOCKHOLDER AND THE COMPANY. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY. 

(d)    The Company shall be obligated to reissue promptly unlegended certificates at the request of any Holder
thereof if the Company has completed its Initial Offering and the Holder shall have obtained an opinion of counsel (which counsel may be counsel to the Company) reasonably acceptable to the Company to the effect that the securities proposed to be
disposed of may lawfully be so disposed of without registration, qualification and legend, and provided that the second legend listed above shall be removed only at such time as the Holder of such certificate is no longer subject to any restrictions
hereunder. 
 (e)    Any legend endorsed on an instrument pursuant to applicable state securities laws and the
stop-transfer instructions with respect to such securities shall be removed upon receipt by the Company of an order of the appropriate blue sky authority authorizing such removal or an opinion of counsel reasonably acceptable to the Company to the
effect that such legend may be removed. 
 2.2    Demand Registration. 

(a)    Subject to the conditions of this Section 2.2, if the Company shall receive a written request from the
Requisite Senior Preferred Majority (the “Initiating Holders”) that the Company file a registration statement under the Securities Act covering the registration of all or part of the Registrable Securities then outstanding
having an aggregate offering price, before deduction of underwriting discounts and commissions, of at least $10,000,000, then the Company shall, within thirty (30) days of the receipt thereof, give written notice of such request to all Holders,
and subject to the limitations of this Section 2.2, effect, as expeditiously as reasonably possible and in any event within ninety (90) days of the receipt of such request, the registration under the Securities Act of all Senior Preferred
Registrable Securities that all Holders request to be registered and thereafter to use its best efforts to cause the registration statement to be declared effective as soon as practicable. 

(b)    If the Initiating Holders intend to distribute the Senior Preferred Registrable Securities covered by their
request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 2.2 or any request pursuant to Section 2.4 and the 

  
 6 

 
Company shall include such information in the written notice referred to in Section 2.2(a) or Section 2.4(a), as applicable. In such event, the right of any Holder to include its Senior
Preferred Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Senior Preferred Registrable Securities in the underwriting to the extent
provided herein. All Holders proposing to distribute their securities through such underwriting shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting by the Company (which
underwriter or underwriters shall be reasonably acceptable to the Initiating Holders). Notwithstanding any other provision of this Section 2.2 or Section 2.4, if the underwriter advises the Company that marketing factors require a limitation of
the number of securities to be underwritten (including Senior Preferred Registrable Securities) then the Company shall so advise all Holders of Senior Preferred Registrable Securities which would otherwise be underwritten pursuant hereto, and the
number of shares that may be included in the underwriting shall be allocated to the Holders of such Senior Preferred Registrable Securities on a pro rata basis based on the number of Senior Preferred Registrable Securities held by all such
Holders (including the Initiating Holders); provided, however, that the number of shares of Senior Preferred Registrable Securities to be included in such underwriting and registration shall not be reduced unless all other securities of the
Company (including securities held by stockholders of the Company other than the Holders) are first entirely excluded from the underwriting and registration. Any Senior Preferred Registrable Securities excluded or withdrawn from such underwriting
shall be withdrawn from the registration. 
 (c)    The Company shall not be required to effect a registration
pursuant to this Section 2.2: 
 (i)    prior to the earlier of (A) the fifth anniversary of the date
of this Agreement or (B) one hundred eighty (180) days following the effective date of the registration statement pertaining to the Initial Offering; 

(ii)    after the Company has effected two (2) registrations pursuant to this Section 2.2, and such
registrations have been declared or ordered effective; 
 (iii)    if the Company shall furnish to Holders
requesting a registration statement pursuant to this Section 2.2, a certificate signed by the Chairman of the Board (or, if no Chairman has been appointed, then the Chief Executive Officer or President of the Company) stating that in the good
faith judgment of the Board, it would be seriously detrimental to the Company and its stockholders for such registration statement to be effected at such time, in which event the Company shall have the right to defer such filing for a period of not
more than ninety (90) days after receipt of the request of the Initiating Holders; provided that such right to delay a request shall be exercised by the Company not more than once in any twelve (12) month period and provided further
that the Company shall not register any securities for the account of itself or any other stockholder during such ninety (90) day period; 

(iv)    if within thirty (30) days of receipt of a written request from
Initiating Holders pursuant to Section 2.2(a), the Company gives notice to the Holders of the Company’s intention to file a registration statement for its Initial Offering within ninety (90) days; provided that the Company is actively
employing in good faith all commercially reasonable efforts to cause such registration statement to become effective; 

(v)    if the Initiating Holders propose to dispose of shares of Senior Preferred Registrable Securities that may
be immediately registered on Form S-3 pursuant to a request made pursuant to Section 2.4 below; or 

  
 7 

 (vi)    in any particular jurisdiction in which the Company
would be required to qualify to do business or to execute a general consent to service of process in effecting such registration, qualification or compliance, unless the Company is otherwise required to do so. 

2.3    Piggyback Registrations. The Company shall notify all Holders of Registrable Securities in writing at least
fifteen (15) days prior to the filing of any registration statement under the Securities Act for purposes of a public offering of securities of the Company (including, but not limited to, registration statements relating to primary and/or
secondary offerings of securities of the Company, but excluding Special Registration Statements) and will afford each such Holder an opportunity to include in such registration statement all or part of such Registrable Securities held by such
Holder. Each Holder desiring to include in any such registration statement all or any part of the Registrable Securities held by it shall, within fifteen (15) days after the above-described notice from the Company, so notify the Company in
writing. Such notice shall state the intended method of disposition of the Registrable Securities by such Holder. If a Holder decides not to include all of its Registrable Securities in any registration statement thereafter filed by the Company,
such Holder shall nevertheless continue to have the right to include any Registrable Securities in any subsequent registration statement or registration statements as may be filed by the Company with respect to offerings of its securities, all upon
the terms and conditions set forth herein. 
 (a)    Underwriting. If the registration statement under which the
Company gives notice under this Section 2.3 is for an underwritten offering, the Company shall so advise the Holders of Registrable Securities. In such event, the right of any such Holder to include Registrable Securities in a registration
pursuant to this Section 2.3 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities to the extent provided herein. All Holders proposing to distribute their
Registrable Securities through such underwriting shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting by the Company. Notwithstanding any other provision of this Agreement,
if the underwriter determines in good faith that marketing factors require a limitation of the number of shares to be underwritten, the number of shares that may be included in the underwriting shall be allocated, first, to the Company; second, to
the Holders on a pro rata basis based on the total number of Registrable Securities held by such Holders; and third, to any stockholder of the Company (other than a Holder) on a pro rata basis; provided, however, that no such
reduction shall reduce the amount of securities of the selling Holders included in the registration below twenty-five percent (25%) of the total amount of securities included in such registration without the written consent of the Requisite Senior
Preferred Majority, unless such offering is a Qualified Public Offering and such registration does not include shares of any other selling stockholders, in which event any or all of the Registrable Securities of the Holders may be excluded in
accordance with the immediately preceding clause. In no event will shares of any other selling stockholder be included in such registration without the written consent of those Holders of a majority of the Registrable Securities held by the
Investors and proposed to be sold in the offering if such inclusion would reduce the number of shares that may be included by Holders. If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by
written notice to the Company and the underwriter, delivered at least ten (10) business days prior to the effective date of the registration statement. Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded
and withdrawn from the registration. For any Holder which is a partnership, limited liability company or corporation, the partners, retired partners, members, retired members and stockholders of such Holder, or the estates and family members of any
such partners, retired partners, members and retired members and any trusts for the benefit of any of the foregoing person shall be deemed to be a single “Holder,” and any pro rata reduction with respect to such
“Holder” shall be based upon the aggregate amount of shares carrying registration rights owned by all entities and individuals included in such “Holder,” as defined in this sentence. 

  
 8 

 (b)    Right to Terminate Registration. The Company shall have
the right to terminate or withdraw any registration initiated by it under this Section 2.3 prior to the effectiveness of such registration whether or not any Holder has elected to include securities in such registration, and shall promptly
notify any Holder that has elected to include shares in such registration of such termination or withdrawal. The Registration Expenses of such withdrawn registration shall be borne by the Company in accordance with Section 2.5 hereof. 

2.4    Form S-3 Registration. After the Initial Offering, the Company shall
use its commercially reasonable efforts to qualify and remain qualified to register securities on Form S-3 (or any successor to Form S-3). In case the Company shall
receive from any Holder or Holders of Senior Preferred Registrable Securities (the “S-3 Initiating Holders”) a written request or requests that the Company effect a registration on Form
S-3 (or any successor to Form S-3) or any similar short form registration statement and any related qualification or compliance with respect to all or a part of the
Senior Preferred Registrable Securities owned by such S-3 Initiating Holder or Holders, the Company will: 

(a)    promptly give written notice of the proposed registration, and any related qualification or compliance, to
all other Holders of Senior Preferred Registrable Securities; and 
 (b)    as soon as practicable and in any
event within 45 days after the receipt of such request, effect such registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such
Holder’s or Holders’ Senior Preferred Registrable Securities as are specified in such request, together with all or such portion of the Senior Preferred Registrable Securities of any other Holder or Holders joining in such request as are
specified in a written request given within fifteen (15) days after receipt of such written notice from the Company; provided, however, that the Company shall not be obligated to effect any such registration, qualification or
compliance pursuant to this Section 2.4: 
 (i)    if Form S-3 is
not available for such offering by the Holders, or 
 (ii)    if the Holders, together with the holders of any
other securities of the Company entitled to inclusion in such registration, propose to sell Senior Preferred Registrable Securities and such other securities (if any) at an aggregate price to the public of less than one million dollars ($1,000,000),
or 
 (iii)    if within thirty (30) days of receipt of a written request from any Holder or Holders
pursuant to this Section 2.4, the Company gives notice to such Holder or Holders of the Company’s intention to make a public offering within ninety (90) days, other than pursuant to a Special Registration Statement provided
that such Holders were permitted to register such shares as requested to be registered pursuant to Section 2.3 hereof without reduction by the underwriter thereof and provided, further, that the Company is actively employing
in good faith all commercially reasonable efforts to cause such registration statement to become effective; or 

(iv)    if the Company shall furnish to the Holders a certificate signed by the Chairman of the Board (or, if no
Chairman has been appointed, then the Chief Executive Officer or President of the Company) stating that in the good faith judgment of the Board, it would be seriously detrimental to the Company and its stockholders for such Form S-3 registration to be effected at such time, in which event the Company shall have the right to defer the filing of the Form S-3 registration statement for a period of not
more than ninety (90) days after receipt of the request of the Holder or Holders under this Section 2.4; provided, that such right to delay a request shall be exercised by the Company not more than once in any twelve (12) month
period, and provided further that the Company shall not register any securities for the account of itself or any other stockholder during such ninety (90) day period; or 

  
 9 

 (v)    if the Company has, within the twelve (12) month
period preceding the date of such request, already effected two (2) registrations on Form S-3 for the Holders pursuant to this Section 2.4, or 

(vi)    in any particular jurisdiction in which the Company would be required to qualify to do business or to
execute a general consent to service of process in effecting such registration, qualification or compliance, unless the Company is otherwise required to do so. 

(vii)     Subject to the foregoing, the Company shall file a Form
S-3 registration statement covering the Senior Preferred Registrable Securities and other securities so requested to be registered as soon as practicable after receipt of the requests of the S-3 Initiating Holders. Registrations effected pursuant to this Section 2.4 shall not be counted as demands for registration or registrations effected pursuant to Section 2.2. 

2.5    Expenses of Registration. Except as specifically provided herein, all Registration Expenses incurred
in connection with any registration, qualification or compliance pursuant to Section 2.2, Section 2.3 or Section 2.4 herein shall be borne by the Company. All Selling Expenses incurred in connection with any registrations hereunder, shall
be borne by the holders of the securities so registered pro rata on the basis of the number of shares so registered. The Company shall not, however, be required to pay for expenses of any registration proceeding begun pursuant to
Section 2.2 or 2.4, the request of which has been subsequently withdrawn by the Initiating Holders or the S-3 Initiating Holders, as applicable, unless (a) the withdrawal is based upon material
adverse information concerning the Company of which the Initiating Holders were not aware at the time of such request and the Initiating Holders have withdrawn the request with reasonable promptness following disclosure by the Company of such
material adverse information or (b) the Requisite Senior Preferred Majority agrees to deem such registration to have been effected as of the date of such withdrawal for purposes of determining whether the Company shall be obligated pursuant to
Section 2.2(c)(ii) or 2.4(b)(v), as applicable, to undertake any subsequent registration, in which event such right shall be forfeited by all Holders. If the Holders are required to pay the Registration Expenses, such expenses shall be borne by
the Holders of securities (including Registrable Securities) requesting such registration in proportion to the number of shares for which registration was requested and not excluded prior to such withdrawal. If the Company is required to pay the
Registration Expenses of a withdrawn offering pursuant to clause (a) above, then such registration shall not be deemed to have been effected for purposes of determining whether the Company shall be obligated pursuant to Section 2.2(c)(ii)
or 2.4(b)(v), as applicable, to undertake any subsequent registration. All Registration Expenses incurred in connection with registrations requested pursuant to Section 2.2 after the first two (2) registrations (if such registrations have
been declared or ordered effective) shall be paid by the selling Holders pro rata in proportion to the number of shares to be sold by each such Holder in any registration. 

2.6    Obligations of the Company. Whenever required to effect the registration of any Registrable
Securities, the Company shall, as expeditiously as reasonably possible: 
 (a)    Prepare and file with the SEC a
registration statement with respect to such Registrable Securities and use its commercially reasonable efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities
registered thereunder, keep such registration statement effective for a period of at least ninety (90) days (to be measured from the expiration of any lockup period related to such registration, if applicable) or until such earlier time as the
Holder or Holders have completed the distribution related thereto; provided, 

  
 10 

 
however, that at any time, upon written notice to the participating Holders and for a period not to exceed sixty (60) days thereafter (the “Suspension
Period”), the Company may delay the filing or effectiveness of any registration statement or suspend the use or effectiveness of any registration statement (and the Initiating Holders hereby agree not to offer or sell any Registrable
Securities pursuant to such registration statement during the Suspension Period) if the Company reasonably believes that there is or may be in existence material nonpublic information or events involving the Company, the failure of which to be
disclosed in the prospectus included in the registration statement could result in a Violation (as defined below); provided, that the Company shall not offer or sell, and shall not permit any director or officer of the Company to offer or
sell, any securities pursuant to such registration statement during the Suspension Period. In the event that the Company shall exercise its right to delay or suspend the filing or effectiveness of a registration hereunder, the applicable time period
during which the registration statement is to remain effective shall be extended by a period of time equal to the duration of the Suspension Period. The Company may extend the Suspension Period for an additional consecutive sixty (60) days with
the consent of the holders of a majority of the Registrable Securities registered under the applicable registration statement, which consent shall not be unreasonably withheld. In no event shall any Suspension Period, when taken together with all
prior Suspension Periods, exceed 120 days in the aggregate. If so directed by the Company, all Holders registering shares under such registration statement shall (i) not offer to sell any Registrable Securities pursuant to the registration
statement during the period in which the delay or suspension is in effect after receiving notice of such delay or suspension; and (ii) use their commercially reasonable best efforts to deliver to the Company (at the Company’s expense) all
copies, other than permanent file copies then in such Holders’ possession, of the prospectus relating to such Registrable Securities current at the time of receipt of such notice. Notwithstanding the foregoing, the Company shall not be required
to file, cause to become effective or maintain the effectiveness of any registration statement other than a registration statement on Form S-3 that contemplates a distribution of securities on a delayed or
continuous basis pursuant to Rule 415 under the Securities Act. 
 (b)    Prepare and file with the SEC such
amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all
securities covered by such registration statement for the period set forth in subsection (a) above. 

(c)    Furnish to the Holders such number of copies of a prospectus, including a preliminary prospectus, in
conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them. 

(d)    Use all reasonable efforts to register and qualify the securities covered by
such registration statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided that the Company shall not be required in connection therewith or as a condition thereto to
qualify to do business or to file a general consent to service of process in any such states or jurisdictions, except to the extent the Company is otherwise so required. 

(e)    In the event of any underwritten public offering, enter into and perform its obligations under an
underwriting agreement, in usual and customary form, with the managing underwriter(s) of such offering. Each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement. 

(f)    Notify each Holder of Registrable Securities covered by such registration
statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an
untrue statement of a material fact or omits to state a material fact 

  
 11 

 
required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing. The Company will use all reasonable efforts to amend or
supplement such prospectus in order to cause such prospectus not to include any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the
light of the circumstances then existing. 
 (g)    Use all reasonable efforts to furnish, on the date that such
Registrable Securities are delivered to the underwriters for sale, if such securities are being sold through underwriters, (i) an opinion, dated as of such date, of the counsel representing the Company for the purposes of such registration, in
form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and (ii) a letter, dated as of such date, from the independent certified public accountants of the Company, in
form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering addressed to the underwriters. 

(h)    Make available to each selling Holder of Registrable Securities, any underwriter participating in any
disposition pursuant to a registration statement, and any attorney, accountant or other agent or representative retained by any such selling Holder or underwriter (collectively, the “Inspectors”), upon request, all financial
and other records, pertinent corporate documents and properties of the Company (collectively, the “Records”), as shall be reasonably necessary to enable them to exercise their due diligence responsibility, and cause the
Company’s officers, directors and employees to supply all information reasonably requested by any such Inspector in connection with such registration statement subject, in each case, to such confidentiality agreements as the Company shall
reasonably request. 
 (i)    Use its commercially reasonable to cause all such Registrable Securities registered
pursuant to such registration statement to be listed on each securities exchange or quoted on the quotation system on which the Common Stock is then listed or quoted (or if the Common Stock is not yet listed or quoted, then on such exchange or
quotation system as the selling Holders of Registrable Securities and the Company shall mutually agree). 

(j)    Provide a transfer agent and registrar for all Registrable Securities registered pursuant hereunder and a
CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration. 

(k)    Otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the
SEC and make generally available to its security holders an earnings statement of the Company which will satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any comparable successor provisions). 

(l)    Otherwise cooperate with the underwriter(s), the SEC and other regulatory agencies and take all reasonable
actions and execute and deliver or cause to be executed and delivered all documents reasonably necessary to effect the registration of any securities under this Agreement. 

2.7    Termination of Registration Rights. All registration rights granted under this Section 2 shall
terminate and be of no further force and effect upon the earlier of (i) five (5) years after the date of the Company’s first Qualified Public Offering or (ii) an Acquisition or (iii) an Asset Transfer or Liquidation Event (each,
as defined in the Certificate). 

  
 12 

 2.8    Delay of Registration; Furnishing Information. 

(a)    No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any such
registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

(b)    It shall be a condition precedent to the obligations of the Company to take any
action pursuant to Section 2.2, 2.3 or 2.4 that the selling Holders shall furnish to the Company such information regarding themselves, the Registrable Securities held by them and the intended method of disposition of such securities as shall
be required to effect the registration of their Registrable Securities. 
 (c)    The Company shall have no
obligation with respect to any registration requested pursuant to Section 2.2 or Section 2.4 if, due to the operation of subsection 2.2(b), the number of shares or the anticipated aggregate offering price of the Registrable Securities to
be included in the registration does not equal or exceed the number of shares or the anticipated aggregate offering price required to originally trigger the Company’s obligation to initiate such registration as specified in Section 2.2 or
Section 2.4, whichever is applicable. 
 2.9    Indemnification. In the event any Registrable
Securities are included in a registration statement under Sections 2.2, 2.3 or 2.4: 
 (a)    To the extent
permitted by law, the Company will indemnify and hold harmless each Holder, the partners, members, officers and directors of each Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such
Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange Act or other federal
or state law, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”) by the
Company: (i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement or incorporated by reference therein, including any preliminary prospectus or final prospectus contained therein or any
amendments or supplements thereto, (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged
violation by the Company of the Securities Act, the Exchange Act, any state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law in connection with the offering covered by such
registration statement; and the Company will reimburse, as incurred, each such Holder, partner, member, officer, director, underwriter or controlling person for any legal or other expenses reasonably incurred by them in connection with investigating
or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained in this Section 2.9(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability
or action if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that
it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration by such Holder, partner, member, officer, director, underwriter
or controlling person of such Holder. 
 (b)    To the extent permitted by law, each Holder will, if Registrable
Securities held by such Holder are included in the securities as to which such registration qualifications or compliance is being effected, indemnify and hold harmless the Company, each of its directors, its officers and each person, if any, who
controls the Company within the meaning of the Securities Act, any underwriter and any other Holder selling securities under such registration statement or any of such other Holder’s partners, members, directors or officers or any person who
controls such Holder, against any losses, claims, damages or liabilities (joint or several) to which the Company or any such partner, member, 

  
 13 

 director, officer, controlling person, underwriter or other such Holder, or partner, member, director,
officer or controlling person of such other Holder may become subject under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or
are based upon any of the following statements, omissions or violations: (i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement or incorporated by reference therein, including any
preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements
therein not misleading, or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law (collectively, a “Holder Violation”), in each case to the extent (and
only to the extent) that such Holder Violation occurs in reliance upon and in conformity with written information furnished by such Holder under an instrument duly executed by such Holder and stated to be specifically for use in connection with such
registration; and each such Holder will reimburse as incurred any legal or other expenses reasonably incurred by the Company or any such director, officer, controlling person, underwriter or other Holder, or partner, member, officer, director or
controlling person of such other Holder in connection with investigating or defending any such loss, claim, damage, liability or action if it is judicially determined that there was such a Holder Violation; provided, however, that the
indemnity agreement contained in this Section 2.9(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be
unreasonably withheld; provided further, that in no event shall any indemnity under this Section 2.9(b) exceed the net proceeds from the offering received by such Holder when combined with any amounts contributed under
Section 2.9(d) by such Holder. 
 (c)    Promptly after receipt by an indemnified party under this
Section 2.9 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.9, deliver to the
indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to
assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party shall have the right to retain its own counsel, with the fees and expenses to be paid by the indemnifying party,
if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in
such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall relieve such indemnifying party of any liability to the indemnified party under this
Section 2.9 to the extent, and only to the extent, such failure is prejudicial to its ability to defend such action, but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have
to any indemnified party otherwise than under this Section 2.9. 
 (d)    If the indemnification provided
for in this Section 2.9 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any losses, claims, damages or liabilities referred to herein, the indemnifying party, in lieu of indemnifying such
indemnified party thereunder, shall to the extent permitted by applicable law contribute to the amount paid or payable by such indemnified party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the
relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with the Violation(s) or Holder Violation(s) that resulted in such loss, claim, damage or liability, as well as any other relevant
equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by a court of law by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the
omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party 

  
 14 

 
and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission; provided, that in no event shall any contribution
by a Holder hereunder, when combined with any amounts contributed under Section 2.9(b), exceed the net proceeds from the offering received by such Holder. 

(e)    Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution
contained in the underwriting agreement entered into in connection with the underwritten public offering conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

(f)    The obligations of the Company and Holders under this Section 2.9 shall survive completion of any
offering of Registrable Securities in a registration statement and, with respect to liability arising from an offering to which this Section 2.9 would apply that is covered by a registration filed before termination of this Agreement, such
termination. No indemnifying party, in the defense of any such claim or litigation, shall, except with the consent of each indemnified party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation. 

2.10    Assignment of Registration Rights. The rights to cause the Company to register Registrable
Securities pursuant to this Section 2 may be assigned by a Holder to a transferee or assignee of Registrable Securities (for so long as such shares remain Registrable Securities) that (a) is a subsidiary, parent, general partner, limited
partner, retired partner, member or retired member, affiliated venture capital fund or stockholder of a Holder, (b) is a Holder’s family member or trust, limited partnership or limited liability company for the benefit of an individual
Holder, (c) acquires at least 500,000 shares of Registrable Securities (as adjusted for any stock dividends, combinations, splits, recapitalizations and the like after the date hereof) or (d) is an entity affiliated by common control (or
other related entity) with such Holder; provided, however, (i) the transferor shall furnish to the Company written notice of the name and address of such transferee or assignee and the securities with respect to which such
registration rights are being assigned and (ii) such transferee shall agree in writing to be subject to all restrictions set forth in this Agreement. 

2.11    Amendment of Registration Rights. Any provision of this Section 2 may be amended and the
observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the Requisite Senior Preferred Majority; provided, however,
that the rights under this Section 2 of those Investors holding the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series H-1 Preferred Stock (collectively, the
“Prior Preferred Stock”) may be amended or waived only with the written consent of those Investors holding a majority of the then-outstanding shares of Prior Preferred Stock (excluding the Series H-1 Preferred Stock). Any amendment or waiver effected in accordance with this Section 2.11 shall be binding upon each Holder and the Company. By acceptance of any benefits under this Section 2, Holders of
Registrable Securities hereby agree to be bound by the provisions hereunder. 
 2.12     Limitation on
Subsequent Registration Rights. After the date of this Agreement, the Company shall not, without the prior written consent of the Requisite Senior Preferred Majority, enter into any agreement with any holder or prospective holder of any
securities of the Company that would grant such holder registration rights on a parity with or senior to those granted to the Holders hereunder, other than the right to a Special Registration Statement. 

2.13    “Market
Stand-Off” Agreement. Each Holder hereby agrees that such Holder shall not offer, sell, pledge, transfer, make any short sale of, grant any option for the purchase of, or enter into any

  
 15 

 
swap, hedging or similar arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Common Stock (or other securities) of the Company held by
such Investor prior to the effective date of the registration statement (other than those included in the registration) for a period specified by the representative of the underwriters of Common Stock (or other securities) of the Company not to
exceed (i) one hundred eighty (180) days (or such longer period, not to exceed 18 days after the expiration of the 180-day period, as the underwriters or the Company shall request in order to
facilitate compliance with FINRA Rule 2241 or any successor or similar rules or regulations), or (ii) for those Holders included on EXHIBIT B attached hereto (as may be amended from time to time) (each, a
“Strategic Investor”), such longer period, not to exceed three hundred sixty (360) days, as may be determined by the Company (as applicable, the “Restricted Period”), in each case following the
effective date of a registration statement of the Company filed under the Securities Act; provided that: 

(a)    such agreement shall apply only to the Company’s Initial Offering and, upon the approval of the
Requisite Senior Preferred Majority, for a period of up to ninety (90) days following a secondary offering occurring prior to the end of the Restricted Period; 

(b)    all officers and directors of the Company and holders of at least one percent (1%) of the Company’s
voting securities enter into similar agreements; and 
 (c)    such agreement shall provide that any
discretionary waiver or termination of the restrictions of such agreement by the Company or the representative of the underwriters of Common Stock (or other securities) of the Company, shall apply pro rata to each Investor subject to such
agreement, based on the number of shares of capital stock held by such Investor and its affiliates on one hand and the holders of capital stock receiving the waiver or termination of such restrictions on the other hand. 

2.14    Agreement to Furnish Information. Each Holder agrees to execute and deliver such other
agreements as may be reasonably requested by the Company or the underwriter that are consistent with the Holder’s obligations under Section 2.13 or that are necessary to give further effect thereto. In addition, if requested by the Company
or the representative of the underwriters of Common Stock (or other securities) of the Company, each Holder shall provide, within ten (10) days of such request, such information as may be required by the Company or such representative in
connection with the completion of any public offering of the Company’s securities pursuant to a registration statement filed under the Securities Act. The obligations described in Section 2.13 and this Section 2.14 shall not apply to
a Special Registration Statement. The Company may impose stop-transfer instructions with respect to the shares of Common Stock (or other securities) subject to the foregoing restriction until the end of the Restricted Period. Prior to the Initial
Offering, each Holder agrees that any transferee of any shares of Registrable Securities shall be bound by Sections 2.13 and 2.14. The underwriters of the Company’s stock are intended third party beneficiaries of Sections 2.13 and 2.14 and
shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. 

2.15    Rule 144 Reporting. With a view to making available to the Holders the benefits of certain
rules and regulations of the SEC which may permit the sale of the Registrable Securities to the public without registration, the Company agrees that, at all times when the Company is subject to the reporting requirements of the Securities Act and of
the Exchange Act, it shall use its best efforts to: 
 (a)    Make and keep public information available, as
those terms are understood and defined in SEC Rule 144 or any similar or analogous rule promulgated under the Securities Act, at all times after the effective date of the first registration filed by the Company for an offering of its securities to
the general public; 

  
 16 

 (b)    File with the SEC, in a timely manner, all reports and
other documents required of the Company under the Exchange Act; and 
 (c)    So long as a Holder owns any
Registrable Securities, furnish to such Holder forthwith upon request: a written statement by the Company as to its compliance with the reporting requirements of said Rule 144 of the Securities Act, and of the Exchange Act (at any time after it has
become subject to such reporting requirements); a copy of the most recent annual or quarterly report of the Company filed with the Commission; and such other reports and documents as a Holder may reasonably request in connection with availing itself
of any rule or regulation of the SEC allowing it to sell any such securities without registration. 
  

	3.	 COVENANTS OF THE COMPANY. 

3.1    Basic Financial Information and Reporting. 

(a)    The Company will maintain true books and records of account in which full and correct entries will be made of
all its business transactions pursuant to a system of accounting established and administered in accordance with generally accepted accounting principles consistently applied (except as noted therein), and will set aside on its books all such proper
accruals and reserves as shall be required under generally accepted accounting principles consistently applied. 

(b)    As soon as practicable after the end of each fiscal year of the Company, and in any event within one hundred
eighty (180) days thereafter, the Company will furnish each Major Investor with an audited balance sheet of the Company, as at the end of such fiscal year, and the related audited statement of income, a statement of stockholders’ equity,
and a statement of cash flows of the Company, for such year, all prepared in accordance with generally accepted accounting principles consistently applied (except as noted therein) and setting forth in each case in comparative form the figures for
the previous fiscal year, all in reasonable detail. Such financial statements shall be accompanied by a report and opinion thereon by independent public accountants of national or regional standing as selected by the Board. 

(c)    The Company will furnish each Major Investor as soon as practicable after the end of the first, second and
third quarterly accounting periods in each fiscal year of the Company, and in any event within forty-five (45) days thereafter, a balance sheet of the Company as of the end of each such quarterly period, and a statement of income and a
statement of cash flows of the Company for such period and for the current fiscal year to date, prepared in accordance with generally accepted accounting principles consistently applied (except as noted therein or as disclosed to the recipients
thereof), with the exception that no notes need be attached to such statements and year-end audit adjustments may not have been made. 

(d)    The Company will furnish each Major Investor as soon as practicable after the end of each month, and in any
event within thirty (30) days thereafter, a balance sheet of the Company as of the end of each such month, and a statement of income and a statement of cash flows of the Company for such month and for the current fiscal year to date, including
a comparison to plan figures for such period, prepared in accordance with generally accepted accounting principles consistently applied (except as noted thereon), with the exception that no notes need be attached to such statements and year-end audit adjustments may not have been made. 

  
 17 

 (e)    The Company will furnish each Major Investor at least
thirty (30) days prior to the beginning of each fiscal year (and as soon as available, any subsequent written revisions thereto) a comprehensive operating budget forecasting the Company’s revenues, expenses, and cash position on a month-to-month basis for the upcoming fiscal year (a “Budget”). Each Budget shall be prepared in accordance with generally accepted accounting
principles consistently applied (except as noted thereon). Each Budget shall be presented to the Board for approval at least sixty (60) days prior to such fiscal year. 

(f)    All financial information and budgets required under Section 3.1(b)-(e) above shall consist of
consolidated financial statements (consolidating the Company and its subsidiaries) unless the rules of generally accepted accounting principles provide otherwise. 

Notwithstanding anything else in this Subsection 3.1 to the contrary, the Company may cease providing the information set forth in this
Subsection 3.1 during the period starting with the date sixty (60) days before the Company’s good-faith estimate of the date of filing or submission of a registration statement if it reasonably concludes it must do so to comply with the
SEC rules applicable to such registration statement and related offering. 
 3.2    Other Materials. As
soon as practicable (or otherwise as provided herein), the Company and furnish each Major Investor with copies of the following documents: 

(a)    Material documents filed with governmental agencies on behalf of the Company, including, without limitation,
the Internal Revenue Service and the SEC, within thirty (30) days after filing; 
 (b)    Pleadings of any
material lawsuits filed by or against any of the Company, within thirty (30) days after filing or service of process; 

(c)    Notices regarding any default on any loan or lease to which the Company is a party within five (5) days
after discovery (such notices to contain a statement outlining such default and management’s proposed response); and 

(d)    Any other documents or information pertaining to the Company reasonably requested by a Major Investor,
unless the Board determines in good faith that the documents or information requested is confidential or attorney-client privileged or that the documents contain information related to trade secrets and related intellectual property and should not,
therefore, be disclosed. 
 Notwithstanding anything else in this Subsection 3.2 to the contrary, the Company may cease providing the
information set forth in this Subsection 3.2 during the period starting with the date sixty (60) days before the Company’s good-faith estimate of the date of filing or submission of a registration statement if it reasonably concludes it
must do so to comply with the SEC rules applicable to such registration statement and related offering. 

3.3    Inspection Rights. Each Major Investor shall have the right, upon reasonable prior notice and during
business hours, to visit and inspect any of the properties of the Company or any of its subsidiaries, and to discuss the affairs, finances and accounts of the Company or any of its subsidiaries with its officers, and to review such information as is
reasonably requested all at such reasonable times and as often as may be reasonably requested; provided, however, that the Company shall not be obligated under this Section 3.3 with respect to a competitor or strategic investor of
the Company (as reasonably determined by the Board) (for the sake of clarity, a Major Investor that is a venture capital fund shall not be deemed to be a competitor or strategic investor of the Company merely because it has a portfolio company that
is a competitor to the Company) or with respect to information which the Board determines in good faith is confidential or attorney-client privileged and should not, therefore, be disclosed. 

  
 18 

 3.4    Confidentiality of Records. Each Major Investor agrees to
keep confidential, and to use the same degree of care as such Investor uses to protect its own confidential information, but in no event less than a commercially reasonable degree of care, to keep confidential any information furnished to such
Investor that the Company identifies as being confidential or proprietary (so long as such information is not in the public domain), except that such Investor may disclose such proprietary or confidential information (i) to any partner,
subsidiary or parent of such Investor as long as such partner, subsidiary or parent is advised of and agrees or has agreed to be bound by the confidentiality provisions of this Section 3.4 or comparable restrictions, and with respect to any
Investor that is affiliated with a venture capital firm, to its partners, members, former partners or members who retained an economic interest in such Investor, current or prospective partners or members or any other partnership under common
investment management of such Investor, management company, legal counsel, representatives or accountants in connection with communications in the ordinary course of business; (ii) at such time as it enters the public domain through no fault of
such Major Investor; (iii) that is communicated to it free of any obligation of confidentiality; (iv) that is developed by Major Investor or its agents independently of and without reference to any confidential information communicated by
the Company; or (v) as required by applicable law, rule or regulation. 
 3.5    Reservation of Common
Stock. The Company will at all times reserve and keep available, solely for issuance and delivery upon the conversion of the Preferred Stock, all Common Stock issuable from time to time upon such conversion. 

3.6    Stock Vesting. Unless otherwise approved by the Board, all restricted stock, stock options and other stock
equivalents issued after the date of this Agreement to employees, directors, consultants and other service providers shall be subject to vesting as follows: (a) twenty-five percent (25%) of such stock shall vest at the end of the first year
following the earlier of the date of issuance or such person’s services commencement date with the Company, and (b) seventy-percent (75%) of such stock shall vest monthly over the remaining three (3) years; provided that all
restricted stock, stock options and other stock equivalents granted to employees that have served as an employee for more than a year at the time of such grant shall vest monthly over four (4) years (the “Normal Vesting
Schedule”). With respect to any shares of restricted stock purchased by any such person, the Company’s repurchase option shall provide (to the extent in compliance with applicable law) that upon such person’s termination of
employment or service with the Company, with or without cause, the Company or its assignee shall have the option to purchase at the lower of cost or fair market value, as determined by the Board in good faith, any unvested shares of stock held by
such person. Unless otherwise approved by the Board, after the date of this Agreement the Company shall not grant any stock option or stock equivalent providing for vesting provisions that differ from the Normal Vesting Schedule or accelerate the
vesting upon an Acquisition or an Asset Transfer (as defined in the Certificate), termination of employment or similar event. 

3.7    Board of Directors. 

(a)    The authorized size of the Board shall be seven (7) members unless approved by a majority of the Board,
including the Series D Designee and the Series F Designee. 
 (b)    The Company will reimburse each outside
director for his or her reasonable expenses incurred in the course of Company business (including, without limitation in attending meetings of the Board (including the committees thereof) and any other meetings or events attended on behalf of the
Company at the Company’s request (such as trade shows), so long as such travel is consistent with the Company’s travel policies). 

  
 19 

 (c)    Meetings of the Board shall take place no less than
quarterly until such time as the Board, votes to schedule such meetings less frequently. 
 (d)    The Series D
Designee shall have the right to be a member of each committee of the Board. 
 3.8    Approval of Certain
Transactions. The Company will not, and will not permit any Subsidiary to take any of the following actions, unless previously approved by a majority of the Board, including the Series D Designee and the Series F Designee: 

(a)    extend any loan or advance to, or own any stock or other securities of, any Subsidiary or other corporation,
partnership, or other entity unless it is wholly owned by the Company; 

(b)    extend any loan or advance to any person, including, any employee or director,
except advances and similar expenditures in the ordinary course of business; 
 (c)    implement or change the
Company’s cash investment policy; or 
 (d)    enter into any transaction with any director, officer,
founder, affiliate or other related party if the amount exceeds $120,000, other than (A) the issuance of ordinary course equity awards pursuant to the Company’s equity incentive plans, (B) ordinary course matters pertaining to
employment (but excluding matters related to the compensation of any director or executive officer unless approved by a majority of the directors that are disinterested with respect to such matter), (C) arrangements in the ordinary course providing
for indemnification or advancement or reimbursement of expenses, and (D) transactions approved by an authorized committee of the Board. 

3.9    Market Stand-off. All outstanding shares of Common Stock and
Preferred Stock, and all future shares of Common Stock and preferred stock issuable upon the exercise or conversion of outstanding options, warrants or other exercisable or convertible securities shall be subject to a market standoff or
“lockup” agreement of not less than 180 days following the Company’s initial public offering. 

3.10    Right to Conduct Activities. The Company and each Investor hereby acknowledge that some or
all of the Investors are professional investment funds, and as such invest in numerous portfolio companies, some of which may be competitive with the Company’s business. No Investor shall be liable to the Company or to any other Investor for
any claim arising out of, or based upon, (i) the investment by any Investor in any entity competitive to the Company, or (ii) actions taken by any partner, officer, or other representative of any Investor to assist any such competitive
company, whether or not such action was taken as a board member of such competitive company, or otherwise, and whether or not such action has a detrimental effect on the Company. Notwithstanding anything in this Section 3.10 to the contrary,
nothing herein shall be construed as a waiver of any duty of loyalty or obligation of confidentiality with respect to the disclosure of confidential information of the Company. 

3.11    Proprietary Information and Inventions Agreement. The Company shall require all future
employees and consultants of the Company at the time they first begin working for the Company (whether as an employee or as a consultant) to execute and deliver a proprietary information and inventions agreement in a form previously approved by the
Board (or in the case of a consultant, a consulting agreement containing similar provisions), or in such other form containing similar provisions as may be approved by the Board. 

  
 20 

 3.12    Assignment of Right of First Refusal. In the event the
Company elects not to exercise any right of first refusal or right of first offer the Company may have on a proposed transfer of any of the Company’s outstanding capital (other than pursuant to the Right of First Refusal and Co-Sale Agreement, subject to Section 2.2 thereof), the Company shall, to the extent it may do so, and upon the request of a majority of the holders of Senior Preferred Registrable Securities, assign such right
of first refusal or right of first offer to each Major Investor. In the event of such assignment, each Major Investor shall have a right to purchase its pro rata portion of the capital stock proposed to be transferred. Each Major
Investor’s pro rata portion shall be equal to the product obtained by multiplying (i) the aggregate number of shares proposed to be transferred by (ii) a fraction, the numerator of which is the number of outstanding shares of
Common Stock issued or issuable upon the conversion of Preferred Stock held by such Major Investor at the time of the proposed transfer and the denominator of which is the number of outstanding shares of Common Stock issued or issuable upon the
conversion of Preferred Stock owned by all Major Investors at the time of such proposed transfer. The provisions of this Section 3.12 may be waived as to all Major Investors by the written consent of Requisite Senior Preferred Majority. 

3.13    Key Man Insurance. The Company shall maintain in full force and effect term life insurance in the amount of
$2,000,000 on the lives of each of each Founder (for so long as each such individual remains an employee of the Company); naming the Company as beneficiary. Such policies will not be cancelable by the Company without the prior approval of the Board.

 3.14    Directors and Officers Insurance. The Company shall maintain director and officer liability insurance
with an underwriter and with terms acceptable to the Board. The Company shall annually certify such insurance by delivering a copy of such policy to Bessemer Venture Partners VIII, L.P. If requested by the Series D Designee, the Company will add one
designee of the Investors as a notice party for such policy and shall request that the issuer of such policy provide such designee with ten (10) days’ notice before such policy is terminated (for failure to pay premiums or otherwise) or
assigned or before any change is made in the beneficiary thereof. 
 3.15    Directors’ Liability and
Indemnification. 
 (a)    The Certificate and Bylaws (as such may be amended or amended and restated from
time to time) shall provide (a) for limitation of the liability of directors to the maximum extent permitted by law, and (b) for indemnification of directors for acts on behalf of the Company to the maximum extent permitted by law. In the
event any suit is filed or claim is asserted against a director or former director of the Company as a result of such director’s or former director’s service on the Board, the Company will provide such director or former director access to
all records and files of the Company as he or she may reasonably request in defending against or preparing to defend against any such suit or claim; provided that the Company shall not be obligated to provide access to information which the Board
determines in good faith is confidential (and not otherwise subject to a confidentiality agreement) or attorney-client privileged and should not, therefore, be disclosed. 

(b)    The Company hereby acknowledges that one or more of the directors nominated by holders of Preferred Stock
may have certain rights to indemnification, advancement of expenses and/or insurance provided by one or more of the Investors and certain of their affiliates (collectively, the “Fund Indemnitors”) for alleged acts or
omissions in their capacities as directors of the Company. The Company hereby agrees (i) that it is the indemnitor of first resort (i.e., its obligations to any such director are primary and any obligation of the Fund Indemnitors to advance
expenses or to provide indemnification for the same expenses or liabilities incurred by such director are secondary), (ii) that it shall be required to advance the full amount of expenses incurred by such director and shall be liable for the full
amount of all expenses, judgments, penalties, fines and amounts paid in settlement by or on behalf of any such director to the extent legally permitted and as required by the Certificate or Bylaws of the 

  
 21 

 Company (or any agreement between the Company and such director), without regard to any rights such director
may have against the Fund Indemnitors, and, (iii) that it irrevocably waives, relinquishes and releases the Fund Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind in
respect thereof. The Company further agrees that no advancement or payment by the Fund Indemnitors on behalf of any such director with respect to any claim for which such director has sought indemnification from the Company shall affect the
foregoing and the Fund Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of such director against the Company. 

(c)    If the Company or any of its successors or assignees consolidates with or merges into any other Person and
is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, commercially reasonable efforts shall be made so that the successors and assignees of the Company assume the obligations of the
Company with respect to indemnification of members of the Board as in effect immediately before such transaction, whether such obligations are contained in the Company’s Bylaws, the Certificate, or elsewhere, as the case may be. 

3.16    Subsidiary Approval – General. No Subsidiary shall take any action without the approval of the Board
(including the affirmative approval of the Institutional Majority), to the extent approval of the Board (including the affirmative approval of the Institutional Majority) would be required in the event such action was to be taken by the Company
itself notwithstanding the fact that local law applicable to the subsidiary may not require such approval. 

3.17    Founder Activities. Each Founder and the other executive officers of the Company shall devote 100% of their
business time to the Company. Any other professional activities shall require the approval of the Board of Directors. Nothing herein shall prevent any Founder or other executive officer from devoting reasonable time to his or her personal investment
activities. 
 3.18    Publicity. The Company shall not use an Investor’s (excluding holders of
Series H-1 Preferred Stock and any Investor whom the Company reasonably determines to be a competitor or strategic investor) name in any manner, context or format (including reference on or links to websites,
press releases, etc.) without the prior approval of such Investor; provided, however, that such restriction shall not apply to any disclosure by the Company to (i) the Company’s attorneys, accountants, consultants and other professionals
to the extent necessary to obtain their services, (ii) to the Company’s directors, officers, employees, consultants, other services providers and other Affiliates, in each such case, only as reasonably necessary, (iii) as may be
required applicable law and regulations (including the rules of any applicable stock exchange), (iv) to potential acquirors, current and potential investors, and current and potential lenders, and their respective agents, advisers, representatives
and employees, or (v) to a current or prospective underwriter or manager or their counsel in connection with an initial public offering of the Company’s securities pursuant to a registration statement filed by the Company under the
Securities Act. 
 3.19    Anti-Corruption Policy. The Company shall maintain, and will cause each of its
subsidiaries to maintain, systems or internal controls (including, but not limited to, accounting systems, purchasing systems and billing systems) to ensure compliance with the U.S. Foreign Corrupt Practices Act of 1977, as amended, or any other
applicable anti-bribery or anti-corruption law (including without limitation Part 12 of the United States Anti-Terrorism, Crime and Security Act of 2001; the United States Money Laundering Control Act of 1986; the United States International Money
Laundering Abatement and Anti-Terrorist Financing Act of 2001; the United States Foreign Corrupt Practices Act, as amended; and laws applicable in the United Kingdom that prohibit bribery, corrupt practices or money laundering, including, for the
avoidance of doubt, the Bribery Act 2010). 

  
 22 

 3.20    Real Property Holding Covenant. The Company shall notify
the Investors promptly following any “determination date” (as defined in Treasury Regulations section 1.897-2(c)(1)) with respect to which the Company becomes a United States real property holding
corporation within the meaning of Section 897(c)(2) of the Code or if the Company otherwise becomes aware that the Company is a “United States real property holding corporation” within the meaning of Section 897(c)(2) of the
Internal Revenue Code of 1986, as amended (the “Code”). In addition, at any time upon an Investor’s written request, the Company shall issue a statement to such Investor, in form and substance as described in Treasury
Regulations sections 1.897-2(h)(1) and 1.1445-2(c) (or any successor regulations) and signed under penalties of perjury, regarding whether any interest in the Company
constitutes a “U.S. real property interest” within the meaning of Section 897(c) of the Code, together with an executed notice to the Internal Revenue Service described in Treasury Regulations section
1.897-2(h)(2) (or any successor regulation), provided that an Investor may only make such a written request one time per calendar year. Such statement shall be delivered within ten (10) days of the
Investor’s written request therefor. 
 3.21    Termination of Covenants. All covenants of the Company
contained in Section 3 of this Agreement (other than the provisions of Section 3.4 and 3.15(c)) shall expire and terminate upon the earlier of a Qualified Public Offering or an Acquisition, Asset Transfer or Liquidation Event. 

 

	4.	 RIGHTS OF FIRST REFUSAL. 

4.1    Subsequent Offerings. Subject to applicable securities laws, each Major Investor shall have a right of
first refusal to purchase his, her or its pro rata share of all Equity Securities, as defined below, that the Company may, from time to time, propose to sell and issue after the date of this Agreement, other than the Equity Securities
excluded by Section 4.6 hereof. Each Major Investor’s pro rata share is equal to the ratio of (a) the total number of outstanding shares of Registrable Securities held by such Major Investor to (b) the total number of
shares of the Company’s outstanding Common Stock (including all shares of Common Stock issued or issuable upon conversion of the Shares or upon the exercise of any outstanding warrants or options) immediately prior to the issuance of the Equity
Securities. The term “Equity Securities” shall mean (i) any Common Stock, preferred stock or other security of the Company, (ii) any security convertible into or exercisable or exchangeable for, with or without
consideration, any Common Stock, preferred stock or other security (including any option to purchase such a convertible security), (iii) any security carrying any warrant or right to subscribe to or purchase any Common Stock, preferred stock or
other security or (iv) any such warrant or right. 
 4.2    Exercise of Rights. If the Company proposes to
issue any Equity Securities, it shall give each Major Investor written notice of its intention, describing the Equity Securities, the price and the terms and conditions upon which the Company proposes to issue the same. Each Major Investor shall
have fifteen (15) days from the giving of such notice to agree to purchase its pro rata share of the Equity Securities for the price not lower and upon the terms and conditions specified in the notice by giving written notice to the
Company and stating therein the quantity of Equity Securities to be purchased. Notwithstanding the foregoing, the Company shall not be required to offer or sell such Equity Securities to any Major Investor who would cause the Company to be in
violation of applicable federal securities laws by virtue of such offer or sale. 
 4.3    Issuance of Equity
Securities to Other Persons. If not all of the Major Investors elect to purchase their pro rata share of the Equity Securities, then the Company shall promptly notify in writing the Major Investors who do so elect and shall offer such
Major Investors the right to acquire such unsubscribed shares. Each such Major Investor shall be entitled to acquire a proportion of such unsubscribed shares equal to (a) the total number of outstanding shares of Common Stock issued or issuable
upon the conversion of Preferred Stock held by such Major Investor immediately prior to the issuance of such Equity Securities to (b) the total number of outstanding shares of Common Stock issued 

  
 23 

 or issuable upon the conversion of Preferred Stock held by all such Major Investors immediately prior to the
issuance of such Equity Securities. The Major Investors shall have ten (10) days after receipt of such notice to notify the Company of its election to purchase all or a portion thereof of the unsubscribed shares. If the Major Investors fail to
exercise in full the rights of first refusal, the Company shall have sixty (60) days thereafter to sell the Equity Securities in respect of which the Major Investors’ rights were not exercised, at a price and upon general terms and
conditions not materially more favorable to the purchasers thereof than specified in the Company’s notice to the Major Investors pursuant to Section 4.2 hereof. If the Company has not sold such Equity Securities within sixty (60) days
of the notice provided pursuant to Section 4.2, the Company shall not thereafter issue or sell any Equity Securities, without first offering such securities to the Major Investors in the manner provided above. 

4.4    Termination and Waiver of Rights of First Refusal. The rights of first refusal established by this
Section 4 shall not apply to, and shall terminate upon the earlier of (i) the effective date of the Qualified Public Offering or (ii) an Acquisition, Asset Transfer or Liquidation Event. The rights of first refusal established by this
Section 4 may be amended, or any provision waived with respect to a particular transaction with the written consent of the Company and the holders of a majority of then outstanding Registrable Securities held by the Major Investors, which must
include the holders of a majority of each series of Senior Preferred Registrable Securities. 
 4.5    Transfer of
Rights of First Refusal. The rights of first refusal of each Major Investor under this Section 4 may be transferred to the same parties, subject to the same restrictions, as any transfer of registration rights pursuant to Section 2.10,
other than clause (c) thereof. 
 4.6    Excluded Securities. The rights of first refusal established by
this Section 4 shall have no application to the issuance of Equity Securities that are “Excluded Securities” (as such term is defined in the Certificate). 

 

	5.	 MISCELLANEOUS. 

5.1    Commerce Department Compliance. The Company may be required to file reports with the Bureau of Economic
Analysis (the “BEA”) of the US Commerce Department when a U.S. affiliate of a foreign Investor if such foreign Investor, together with its affiliates, directly or indirectly controls ten percent (10%) or more of the voting
securities of the Company. Such foreign Investor that is a foreign individual or entity or a US subsidiary or affiliate of a foreign parent covenants to provide information necessary for the Company to comply with BEA filings required under the
International Investment and Trade in Services Act. 
 5.2    Governing Law. This Agreement shall be governed by
and construed under the laws of the State of Delaware in all respects as such laws are applied to agreements among Delaware residents entered into and performed entirely within Delaware. THE PARTIES TO THIS AGREEMENT HEREBY WAIVE THEIR RIGHT TO A
TRIAL BY JURY WITH RESPECT TO DISPUTES ARISING UNDER THIS AGREEMENT AND THE RELATED AGREEMENTS AND CONSENT TO A BENCH TRIAL WITH THE APPROPRIATE JUDGE ACTING AS THE FINDER OF FACT. The parties agree that any action brought by either party under or
in relation to this Agreement, including without limitation to interpret or enforce any provision of this Agreement, shall be brought in, and each party agrees to and does hereby submit to the jurisdiction and venue of, any state or federal court
located in the County of San Francisco, California. 
 5.3    Successors and Assigns. Except as otherwise
expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the parties hereto and their respective successors, assigns, heirs, executors, and administrators and shall inure to the benefit of and be
enforceable by each 

  
 24 

 person who shall be a holder of Registrable Securities from time to time; provided, however,
that prior to the receipt by the Company of adequate written notice by the applicable Investor of the transfer of any Registrable Securities specifying the full name and address of the transferee, the Company may deem and treat the person listed as
the holder of such shares in its records as the absolute owner and holder of such shares for all purposes, including the payment of dividends or any redemption price. 

5.4    Entire Agreement. This Agreement, the Exhibits and Schedules hereto, the Purchase Agreement and the other
documents delivered pursuant thereto constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof and no party shall be liable or bound to any other in any manner by any oral or written
representations, warranties, covenants and agreements except as specifically set forth herein and therein. Each party expressly represents and warrants that it is not relying on any oral or written representations, warranties, covenants or
agreements outside of this Agreement. 
 5.5    Amendment and Restatement of Prior Agreement. The Prior Agreement
is hereby amended in its entirety and restated herein. Such amendment and restatement is effective upon the execution of this Agreement by the Company and the parties required for an amendment pursuant to Section 5.5 of the Prior Agreement.
Upon such execution, all provisions of, rights granted and covenants made in the Prior Agreement are hereby waived, released and superseded in their entirety and shall have no further force or effect, including, without limitation, any rights of
first refusal and notice period associated therewith otherwise applicable to the transactions contemplated by the Purchase Agreement. 

5.6    Severability. In the event one or more of the provisions of this Agreement should, for any reason, be held
to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable
provision had never been contained herein. 
 5.7    Amendment and Waiver. 

(a)    Except as otherwise expressly provided, this Agreement may be amended or modified only upon the written
consent of the Company and an Institutional Majority; provided, however, that any amendment or modification to this Agreement that would materially and adversely affect the rights, preferences or privileges of any series of Senior
Preferred Registrable Securities under this Agreement in a manner disproportionate to other series of Senior Preferred Registrable Securities (each such series, an “Affected Series”) shall require the prior written consent or
affirmative vote of the holders of a majority of the then-outstanding shares of such Affected Series; provided, further, however, that any amendments to this Agreement that relate to the creation or issuance of a senior, pari
passu or junior security in a bona fide capital raising transaction, which apply equally to all holders of Senior Preferred Registrable Securities, shall not be considered a change to the rights, preferences or privileges of the Senior Preferred
Registrable Securities in a manner that is materially adverse to the Senior Preferred Registrable Securities; provided, further, however, that Exhibit B may be amended by the Company without the consent of the Investors to
include any Additional Purchaser as a Strategic Investor; provided, further, however, that Exhibit B may not be amended by the Company to include an existing Investor not currently set forth on Exhibit B without the consent of
such existing Investor. 
 (b)    For the purposes of determining the number of Holders or Investors entitled to
vote or exercise any rights hereunder, the Company shall be entitled to rely solely on the list of record holders of its stock as maintained by or on behalf of the Company. 

(c)    Any amendment or waiver effected in accordance with this Agreement shall be binding upon each Investor and
Holder of Registrable Securities in accordance with the terms hereof. 

  
 25 

 5.8    Delays or Omissions. It is agreed that no delay or
omission to exercise any right, power, or remedy accruing to any party, upon any breach, default or noncompliance by another party under this Agreement shall impair any such right, power, or remedy, nor shall it be construed to be a waiver of any
such breach, default or noncompliance, or any acquiescence therein, or of any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit, consent, or approval of any kind or character on any
party’s part of any breach, default or noncompliance under the Agreement or any waiver on such party’s part of any provisions or conditions of this Agreement must be in writing and shall be effective only to the extent specifically set
forth in such writing. All remedies, either under this Agreement, by law, or otherwise afforded to any party, shall be cumulative and not alternative. 

5.9    Notices. All notices required or permitted hereunder shall be in writing and shall be deemed effectively
given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient; if not, then on the next business day, (c) five (5) days
after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of
receipt. If notice is given to the Company, it shall be sent to Procore Technologies, Inc., 6309 Carpinteria Avenue, Carpinteria, facsimile (866) 281-2906, Attention: Chief Legal Officer; and a copy (which shall not constitute notice) shall also be
sent to Cooley LLP, 101 California Street, San Francisco, CA 94111, Attention: Rachel Proffitt. All communications shall be sent to the party to be notified at the address as set forth on the signature pages hereof or EXHIBIT A
hereto or at such other address or electronic mail address as such party may designate by ten (10) days advance written notice to the other parties hereto. 

5.10    Titles and Subtitles. The titles of the sections and subsections of this Agreement are for convenience of
reference only and are not to be considered in construing this Agreement. 
 5.11    Counterparts. This Agreement
may be executed (including execution by electronic signature) in one or more counterparts, each of which will be deemed an original, but all of which together shall constitute one instrument. Counterparts may be delivered via facsimile, electronic
mail (including pdf) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

5.12    Aggregation of Stock. All shares of Registrable Securities and all shares of Investor Stock, as applicable,
held or acquired by affiliated entities or persons or persons or entities under common management or control shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. 

5.13    Pronouns. All pronouns contained herein, and any variations thereof, shall be deemed to refer to the
masculine, feminine or neutral, singular or plural, as to the identity of the parties hereto may require. 

5.14    Specific Performance. In addition to any and all other remedies that may be available at law in the event
of any breach of this Agreement, each Investor shall be entitled to specific performance of the agreements and obligations of the Company hereunder and to such other injunction or other equitable relief as may be granted by a court of competent
jurisdiction. 
 5.15    Additional Investors. Notwithstanding anything to the contrary contained herein, if the
Company shall issue additional shares of its Series I Preferred Stock pursuant to the Purchase Agreement, any purchaser of such shares of Series I Preferred Stock (an “Additional Purchaser”) may become a party to this
Agreement by executing and delivering an additional counterpart signature page to this Agreement and shall be deemed an “Investor” hereunder. This Agreement, including without limitation, EXHIBIT
A hereto, shall be amended by the Company without the consent of the Investors to include any Additional Purchasers as “Investors.” 

  
 26 

 5.16     Exhibits. Each Investor
(i) acknowledges and agrees that Exhibit A and Exhibit B shall be deemed confidential information of the Company and (ii) waives any right to receive such exhibits. Notwithstanding the foregoing, the relevant information contained on such
exhibits shall be made available upon the request of an Investor to the extent necessary to comply with the terms of this Agreement or applicable law. Any such information provided shall be subject to the confidentiality provisions of this
Agreement. 
 5.17     Termination. This Agreement shall terminate in its entirety and be of no
further force or effect upon an Acquisition, Asset Transfer or Liquidation Event or upon the written election of the Requisite Senior Preferred Majority. 

[THIS SPACE INTENTIONALLY LEFT BLANK] 

  
 27 

 In Witness Whereof, the parties hereto have executed this Sixth Amended and
Restated Investor Rights Agreement as of the date set forth in the first paragraph hereof. 
  

			
	COMPANY:
	
	Procore Technologies, Inc., a Delaware
	Corporation
		
	By:	 	 /s/ Craig F. Courtemanche

		 	Craig F. Courtemanche, Chief Executive Officer

  
 Signature Page to Sixth
Amended and Restated Investor Rights Agreement 

 IN WITNESS WHEREOF, the parties hereto have executed
this SIXTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set forth in the first paragraph hereof. 

THE INVESTORS: 
 ICONIQ STRATEGIC
PARTNERS IV, L.P., 
 a Cayman Islands exempted limited partnership 

By: ICONIQ Strategic Partners IV GP, L.P., 
 a Cayman Islands
exempted limited partnership 
 Its: General Partner 
 By:
ICONIQ Strategic Partners IV TT GP, Ltd., 
 a Cayman Islands exempted company 

Its: General Partner 
  

			
	By:	 	 /s/ Kevin Foster

	Name:   Kevin Foster
	Title:   Authorized Signatory

 ICONIQ STRATEGIC PARTNERS IV-B, L.P., 

a Cayman Islands exempted limited partnership 
 By: ICONIQ
Strategic Partners IV GP, L.P., 
 a Cayman Islands exempted limited partnership 

Its: General Partner 
 By: ICONIQ Strategic Partners IV TT GP,
Ltd., 
 a Cayman Islands exempted company 
 Its: General
Partner 
  

			
	By:	 	 /s/ Kevin Foster

	Name:   Kevin Foster
	Title:   Authorized Signatory

 ICONIQ STRATEGIC PARTNERS IV CO-INVEST, L.P., P
SERIES 
 By: ICONIQ Strategic Partners IV GP, L.P., 

a Cayman Islands exempted limited partnership 
 Its: General
Partner 
 By: ICONIQ Strategic Partners IV TT GP, Ltd., 
 a
Cayman Islands exempted company 
 Its: General Partner 
  

			
	By:	 	 /s/ Kevin Foster

	Print Name:   Kevin Foster
	Title:   Authorized Signatory

  

SIGNATURE PAGE TO SIXTH AMENDED AND
RESTATED INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties hereto
have executed this SIXTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set forth in the first paragraph
hereof. 
 THE INVESTORS: 
 ICONIQ
STRATEGIC PARTNERS II, L.P., 
 a Cayman Islands exempted limited partnership 

By: ICONIQ Strategic Partners II GP, L.P., 
 a Cayman Islands
exempted limited partnership 
 Its: General Partner 
 By:
ICONIQ Strategic Partners II TT GP, Ltd., 
 a Cayman Islands exempted company 

Its: General Partner 
  

			
	By:	 	 /s/ Kevin Foster

	Print Name:   Kevin Foster
	Title:   Authorized Person

 ICONIQ STRATEGIC PARTNERS II-B, L.P., 

a Cayman Islands exempted limited partnership 
 By: ICONIQ
Strategic Partners II GP, L.P., 
 a Cayman Islands exempted limited partnership 

Its: General Partner 
 By: ICONIQ Strategic Partners II TT GP,
Ltd., 
 a Cayman Islands exempted company 
 Its: General
Partner 
  

			
	By:	 	 /s/ Kevin Foster

	Print Name:   Kevin Foster
	Title:   Authorized Person

 ICONIQ STRATEGIC PARTNERS II CO-INVEST, L.P., 

a Delaware series limited partnership, P Series 
 By: ICONIQ
Strategic Partners II GP, L.P., 
 a Cayman Islands exempted limited partnership 

Its: General Partner 
 By: ICONIQ Strategic Partners II TT GP,
Ltd., 
 a Cayman Islands exempted company 
 Its: General
Partner 
  

			
	 By:
	 	 /s/ Kevin Foster

	 Print Name:   Kevin Foster

	 Title:   Authorized Person

  

SIGNATURE PAGE TO SIXTH AMENDED AND
RESTATED INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties hereto
have executed this SIXTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set forth in
the first paragraph hereof. 
 THE INVESTORS: 

ICONIQ STRATEGIC PARTNERS III, L.P., 

a Cayman Islands exempted limited partnership 
 By: ICONIQ
Strategic Partners III GP, L.P., 
 a Cayman Islands exempted limited partnership 

Its: General Partner 
 By: ICONIQ Strategic Partners III TT GP,
Ltd., 
 a Cayman Islands exempted company 
 Its: General
Partner 
  

			
	By:	 	 /s/ Kevin Foster

	Print Name:   Kevin Foster
	Title:   Authorized Person

 ICONIQ STRATEGIC PARTNERS III-B, L.P., 

a Cayman Islands exempted limited partnership 
 By: ICONIQ
Strategic Partners III GP, L.P., 
 a Cayman Islands exempted limited partnership 

Its: General Partner 
 By: ICONIQ Strategic Partners III TT GP,
Ltd., 
 a Cayman Islands exempted company 
 Its: General
Partner 
  

			
	By:	 	 /s/ Kevin Foster

	Print Name:   Kevin Foster
	Title:   Authorized Person

 ICONIQ STRATEGIC PARTNERS III CO-INVEST, L.P., 

a Delaware series limited partnership, P Series 
 By: ICONIQ
Strategic Partners III GP, L.P., 
 a Cayman Islands exempted limited partnership 

Its: General Partner 
 By: ICONIQ Strategic Partners III TT GP,
Ltd., 
 a Cayman Islands exempted company 
 Its: General
Partner 
  

			
	By:	 	 /s/ Kevin Foster

	Print Name:   Kevin Foster
	Title:   Authorized Person

  

SIGNATURE PAGE TO SIXTH AMENDED AND
RESTATED INVESTOR RIGHTS AGREEMENT 

 In Witness Whereof, the parties hereto have executed this Sixth Amended and
Restated Investor Rights Agreement as of the date set forth in the first paragraph hereof. 
  

			
	THE INVESTORS:
	
	Carpenter GFII Investments, LLC
		
	By:	 	 /s/ Pat Robinson

		 	Pat Robinson, Authorized Signatory
	
	Address:

  
 Signature Page to Sixth
Amended and Restated Investor Rights Agreement 

 In Witness Whereof, the parties hereto have executed this Sixth Amended and
Restated Investor Rights Agreement as of the date set forth in the first paragraph hereof. 
  

			
	THE INVESTORS:
	
	Carpenter OFII Investments, LLC
		
	By:	 	 /s/ Pat Robinson

		 	Pat Robinson, Authorized Signatory
	
	Address:

  
 Signature Page to Sixth
Amended and Restated Investor Rights Agreement 

 In Witness Whereof, the parties hereto have executed this Sixth Amended and
Restated Investor Rights Agreement as of the date set forth in the first paragraph hereof. 
  

			
	THE INVESTORS:
	
	Carpenter OFIV Investments, LLC
		
	By:	 	 /s/ Pat Robinson

		 	Pat Robinson, Authorized Signatory
	
	Address:

  
 Signature Page to Sixth
Amended and Restated Investor Rights Agreement 

 In Witness Whereof, the parties hereto have executed this Sixth Amended and
Restated Investor Rights Agreement as of the date set forth in the first paragraph hereof. 
  

			
	THE INVESTORS:
	
	Bessemer Venture Partners VIII L.P.
		
	By:	 	Deer VIII & Co. L.P., its General Partner
		
	By:	 	Deer VIII & Co. Ltd., its General Partner
		
	By:	 	 /s/ Scott Ring

		 	Scott Ring, General Counsel
	
	Address:

  
 Signature Page to Sixth
Amended and Restated Investor Rights Agreement 

 In Witness Whereof, the parties hereto have executed this Sixth Amended and
Restated Investor Rights Agreement as of the date set forth in the first paragraph hereof. 
  

			
	THE INVESTORS:
	
	Bessemer Venture Partners VIII Institutional L.P.
		
	By:	 	Deer VIII & Co. L.P., its General Partner
		
	By:	 	Deer VIII & Co. Ltd., its General Partner
		
	By:	 	 /s/ Scott Ring

		 	Scott Ring, General Counsel
	
	Address:

  
 Signature Page to Sixth
Amended and Restated Investor Rights Agreement 

 In Witness Whereof, the parties hereto have executed this Sixth Amended and
Restated Investor Rights Agreement as of the date set forth in the first paragraph hereof. 
  

			
	THE INVESTORS:
	
	Tiger Global PIP 11 LLC
		
	By:	 	 /s/ Steven Boyd

		 	Steven Boyd, General Counsel
	
	Address:     [***]
	 	 	                    [***]

  

  
 Signature Page to Sixth
Amended and Restated Investor Rights Agreement 

 In Witness Whereof, the parties hereto have executed this Sixth Amended and
Restated Investor Rights Agreement as of the date set forth in the first paragraph hereof. 
  

	
	THE INVESTORS:
	
	 /s/ Kevin J. O’Connor

	Kevin J. O’Connor
	
	Address: [***]
	  [***]

  
 Signature Page to Sixth
Amended and Restated Investor Rights Agreement 

 IN WITNESS WHEREOF, the parties hereto
have executed this SIXTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set
forth in the first paragraph hereof. 
 THE INVESTORS: 

ARGONAUTIC VENTURES SPC ON BEHALF OF ARGONAUTIC
VERTICAL SERIES PROCORE STRATEGIC OPPORTUNITY FUND I SP 
  

			
	By:	 	 /s/ Viken Douzdjian

	Name:	 	Viken Douzdjian
	Title:	 	Partner

 Address: [***] 
 [***] 

Email: [***]@argonauticventures.com AND 

[***]@argonauticventures.com 

 IN WITNESS WHEREOF, the
parties hereto have executed this SIXTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date set forth in
the first paragraph hereof. 
  
  

			
	THE INVESTORS:
	
	BSOF MASTER FUND L.P.
	
	By: Blackstone Strategic Opportunity Associates L.L.C., its general partner
		
	By	 	 /s/ Peter Koffler

 
			
	Name:	 	Peter Koffler

 
			
	Title:	 	Authorized Person

 
			
	
	 345 Park Avenue, 28th Floor
 New
York, New York 10154
 United States of America

	
	BSOF MASTER FUND II L.P.
	
	By: Blackstone Strategic Opportunity Associates L.L.C., its general partner
		
	By	 	 /s/ Peter Koffler

 
			
	Name:	 	Peter Koffler

 
			
	Title:	 	Authorized Person

 
			
	
	 345 Park Avenue, 28th Floor
 New
York, New York 10154
 United States of AmericaEX-10.1

 Exhibit 10.1 

INDEMNIFICATION AGREEMENT 

This INDEMNIFICATION AGREEMENT (this “Agreement”) is made and
entered into as of [DATE] by and between Procore Technologies, Inc., a Delaware corporation (the “Company”), and ________________________ (“Indemnitee”). 

WITNESSETH THAT: 

WHEREAS, Indemnitee performs a valuable service for the Company; 

WHEREAS, the Board of Directors of the Company (the “Board of Directors”) has
adopted Bylaws (as amended, the “Bylaws”) providing for the indemnification of the officers and directors of the Company to the maximum extent authorized by Section 145 of the Delaware General Corporation Law, as amended
(“Law”); 
 WHEREAS, the Bylaws and the Law, by their
nonexclusive nature, permit contracts between the Company and the officers or directors of the Company with respect to indemnification of such officers or directors; 

WHEREAS, in accordance with the authorization as provided by the Law, the Company may purchase and
maintain a policy or policies of directors’ and officers’ liability insurance (“D&O Insurance”), covering certain liabilities which may be incurred by its officers or directors in the performance of their
obligations to the Company; 
 [WHEREAS, Indemnitee has certain rights to indemnification and/or
insurance provided by _______________________________ and ___________________ and their affiliates (collectively, with the management company associated with such entities, and any entity that serves as the general partner or managing member to such
entities, the “Fund Indemnitors”) which Indemnitee and the Fund Indemnitors intend to be secondary to the primary obligation of the Company to indemnify Indemnitee as provided herein, with the Company’s acknowledgement
and agreement to the foregoing being a material condition to Indemnitee’s willingness to serve on the Board; and] 

WHEREAS, in order to induce Indemnitee to serve, or continue to serve, as a director or officer of the
Company, the Company has determined and agreed to enter into this contract with Indemnitee[ with the explicit acknowledgement of the intended third party beneficiaries set forth in Section 2 hereof]. 

NOW, THEREFORE, in consideration of Indemnitee’s service, or agreement to serve, as a
director or officer of the Company, the parties hereto agree as follows: 
 1. Indemnity of Indemnitee. The Company hereby agrees to
hold harmless and indemnify Indemnitee to the fullest extent permitted by law, as such may be amended from time to time. In furtherance of the foregoing indemnification, and without limiting the generality thereof: 

  
 Page 1 

 (a) Proceedings Other Than Proceedings by or in the Right of the Company. Indemnitee
shall be entitled to the rights of indemnification provided in this Section 1(a) if, by reason of Indemnitee’s Corporate Status (as defined below), Indemnitee is, or is threatened to be made, a party to or participant in any Proceeding (as
defined below) other than a Proceeding by or in the right of the Company. Pursuant to this Section 1(a), Indemnitee shall be indemnified against all Expenses (as defined below) and Liabilities (as defined below) incurred or paid by Indemnitee
or on Indemnitee’s behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company
and, with respect to any criminal Proceeding, Indemnitee had no reasonable cause to believe Indemnitee’s conduct was unlawful. 
 (b)
Proceedings by or in the Right of the Company. Indemnitee shall be entitled to the rights of indemnification provided in this Section 1(b) if, by reason of Indemnitee’s Corporate Status, Indemnitee is, or is threatened to be made, a
party to or participant in any Proceeding brought by or in the right of the Company. Pursuant to this Section 1(b), Indemnitee shall be indemnified against all Expenses incurred or paid by Indemnitee or on Indemnitee’s behalf in connection
with such Proceeding if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company; provided, however, that, if applicable law so provides, no indemnification against
such Expenses shall be made in respect of any claim, issue or matter in such Proceeding as to which Indemnitee shall have been adjudged to be liable to the Company unless and to the extent that the Court of Chancery of the State of Delaware shall
determine that such indemnification may be made. 
 (c) Indemnification for Expenses of a Party Who is Wholly or Partly Successful.
Notwithstanding and in addition to any other provision of this Agreement, to the extent that Indemnitee is, by reason of Indemnitee’s Corporate Status, a party to and is successful, on the merits or otherwise, in any Proceeding, Indemnitee
shall be indemnified to the maximum extent permitted by law against all Expenses incurred or paid by Indemnitee or on Indemnitee’s behalf in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on
the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses incurred or paid by Indemnitee or on Indemnitee’s behalf in connection with
each successfully resolved claim, issue or matter. For purposes of this Section and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful
result as to such claim, issue or matter. 
 (d) Indemnity of Indemnitee by Subsidiary of Company. Notwithstanding and in addition to
any other provision of this Agreement, in the event that Indemnitee serves, now or in the future, as a director, officer, member of the board of managers or in a similar position with any of the Company’s subsidiaries, in consideration for such
service, Indemnitee shall be indemnified and be entitled to rights of advancement and contribution from any such subsidiary to the maximum extent permitted by this Agreement and by law. Such indemnification, advancement and contribution shall be
made pursuant to comparable procedures as those set forth in this Agreement. The Company hereby represents that it is or will be duly authorized and empowered on behalf of each such subsidiary described in the preceding sentence to provide such
indemnification, advancement and contribution as set forth in this Section 1(d) and further agrees to take any and all actions necessary to cause each such subsidiary to effectuate such indemnification, advancement and contribution. In the
event that any such subsidiary against which Indemnitee is entitled to such indemnification, advancement and contribution fails to 

  
 Page 2 

 
provide such indemnification, advancement or contribution to the maximum extent permitted by this Agreement and by law, the Company agrees to provide to Indemnitee any and all indemnification,
advancement and contribution to the maximum extent permitted by this Agreement and by law on behalf of such subsidiary. The rights of indemnification, advancement and contribution provided to Indemnitee by any subsidiary of the Company are not
exclusive of any other rights which Indemnitee may have from such subsidiary under statute, bylaw, agreement, vote of the board of directors or board of managers of such subsidiary or otherwise. 

2. Additional Indemnity. 

(a) In addition to, and without regard to any limitations on, the indemnification provided for in Section 1, the Company shall and hereby
does indemnify and hold harmless Indemnitee against all Expenses and Liabilities incurred or paid by Indemnitee or on Indemnitee’s behalf if, by reason of Indemnitee’s Corporate Status, Indemnitee is, or is threatened to be made, a party
to or participant in any Proceeding (including a Proceeding by or in the right of the Company), including, without limitation, all liability arising out of the negligence or active or passive wrongdoing of Indemnitee. The only limitation that shall
exist upon the Company’s obligations pursuant to this Agreement shall be that the Company shall not be obligated to make any payment to Indemnitee that is finally determined (under the procedures, and subject to the presumptions, set forth in
Sections 6, 7 and 22 hereof) to be unlawful under Delaware law. 
 [(b) If any Fund Indemnitor, as defined above, is or was a party or is
threatened to be made a party to or is otherwise involved in (including, without limitation, as a witness or responding to discovery) any Proceeding, and such Fund Indemnitor’s involvement in the Proceeding arises from the Indemnitee’s
Corporate Status, or from a Fund Indemnitor’s (or group of Fund Indemnitors) financial interest (whether through equity, debt or otherwise) in or control or alleged control of the Company, then such Fund Indemnitor shall be entitled to all of
the indemnification rights and remedies (including, without limitation, the advancement of Expenses), and shall to the extent indemnified hereunder undertake the obligations, of the Indemnitee under this Agreement to the same extent as the
Indemnitee. The Company and Indemnitee agree that the Fund Indemnitors are express third party beneficiaries of the terms hereof.] 
 3.
Contribution in the Event of Joint Liability. 
 (a) Whether or not the indemnification provided in Sections 1 and 2 hereof is
available, in respect of any threatened, pending or completed action, suit or proceeding in which Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), Company shall pay, in the first instance, the
entire amount of any judgment or settlement of such action, suit or proceeding without requiring Indemnitee to contribute to such payment and Company hereby waives and relinquishes any right of contribution it may have against Indemnitee. Company
shall not enter into any settlement of any action, suit or proceeding in which Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding) unless such settlement provides for a full and final release of all
claims asserted against Indemnitee. 

  
 Page 3 

 (b) Without diminishing or impairing the obligations of the Company set forth in the
preceding subparagraph, if, for any reason, Indemnitee shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed action, suit or proceeding in which Company is jointly liable with
Indemnitee (or would be if joined in such action, suit or proceeding), Company shall contribute to the amount of Expenses and Liabilities incurred or paid by Indemnitee or on Indemnitee’s behalf in proportion to the relative benefits received
by the Company and all officers, directors or employees of the Company other than the parties who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, from
the transaction from which such action, suit or proceeding arose; provided, however, that the proportion determined on the basis of relative benefit may, to the extent necessary to conform to law, be further adjusted by reference to the relative
fault of Company and all officers, directors or employees of the Company other than the parties who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, in
connection with the events that resulted in such Expenses and Liabilities, as well as any other equitable considerations which the law may require to be considered. 

(c) Company hereby agrees to fully indemnify and hold Indemnitee harmless from any claims of contribution which may be brought by officers,
directors or employees of the Company other than the parties who may be jointly liable with Indemnitee. 
 (d) To the fullest extent
permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee,
whether for Liabilities and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order
to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii) the relative fault of the Company (and its directors, officers,
employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s). 
 4. Indemnification for Expenses of a
Witness or in Response to a Subpoena. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is a witness or is made to (or asked to) respond to discovery requests in any Proceeding involving the Company, its
officers, directors, shareholders or creditors to which Indemnitee is not a party, Indemnitee shall be indemnified against all Expenses paid or incurred by Indemnitee in connection therewith and in the manner set forth in this Agreement. 

5. Advancement of Expenses. Notwithstanding any other provision of this Agreement, the Company shall advance all Expenses incurred or
paid by or on behalf of Indemnitee in connection with any Proceeding within ten (10) days after the receipt by the Company of a statement or statements from Indemnitee requesting such advance or advances from time to time, whether prior to or
after final disposition of such Proceeding. Such statement or statements shall reasonably evidence the Expenses incurred or paid by Indemnitee. Any advances and undertakings to repay pursuant to this Section 5 shall be unsecured and interest
free and made without regard to Indemnitee’s financial ability to repay such Expenses. Indemnitee shall qualify for advances upon the execution and delivery to the Company of this Agreement, which shall constitute an undertaking providing that
Indemnitee undertakes to the fullest extent permitted by law to repay the advance (without interest) if and to the extent that it is ultimately determined by a court of competent jurisdiction in a final judgment, not subject to further appeal, that
Indemnitee is not entitled to be indemnified by the Company. No other form of undertaking shall be required other than the execution of this Agreement. 

  
 Page 4 

 6. Procedures and Presumptions for Determination of Entitlement to Indemnification.
It is the intent of this Agreement to secure for Indemnitee rights of indemnity that are at least as favorable as may be permitted under the Law and public policy of the State of Delaware. Accordingly, the parties agree that the following procedures
and presumptions shall apply in the event of any question as to whether Indemnitee is entitled to indemnification under this Agreement: 

(a) To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request including therein or therewith
such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification; provided, however, that failure to so notify the Company shall
not relieve the Company of any of its obligations hereunder. The Secretary of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board of Directors in writing that Indemnitee has requested indemnification.
Notwithstanding anything in this Agreement to the contrary, no determination (if required by applicable law) as to entitlement to indemnification under this Agreement shall be required to be made prior to the final disposition of the Proceeding.

 (b) Upon written request by Indemnitee for indemnification pursuant to the first sentence of Section 6(a) hereof, a determination, if
required by a court of law, with respect to Indemnitee’s entitlement thereto shall be made in the specific case by one of the following four methods, which shall be at the election of Indemnitee: (1) by a majority vote of the Disinterested
Directors (as defined below), even though less than a quorum, or (2) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum, or (3) by independent legal
counsel in a written opinion to the Board of Directors, a copy of which shall be delivered to Indemnitee, or (4) by the stockholders. 

(c) If the determination of entitlement to indemnification is to be made by Independent Counsel (as defined below) pursuant to
Section 6(b) hereof, the Independent Counsel shall be selected as provided in this Section 6(c). The Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board of
Directors). Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such
selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Section 15 of this Agreement, and the
objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If a written objection is made and substantiated, the Independent
Counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit. If, within twenty (20) days after submission by Indemnitee of a written request
for indemnification pursuant to Section 6(a) hereof, no Independent Counsel shall have been selected and not objected to, then either the Company or Indemnitee may petition the Court of Chancery of

  
 Page 5 

 
the State of Delaware or other court of competent jurisdiction for resolution of any objection which shall have been made by the Company or Indemnitee, as the case may be, to Indemnitee’s or
the Board of Directors’, respectively, selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other person as the court shall designate, and the person with respect to
whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 6(b) hereof. The Company shall pay any and all reasonable fees and expenses of Independent Counsel incurred or paid by such
Independent Counsel in connection with acting pursuant to Section 6(b) hereof, and the Company shall pay all reasonable fees and expenses incident to the procedures of this Section 6(c), regardless of the manner in which such Independent
Counsel was selected or appointed. 
 (d) In making a determination with respect to entitlement to indemnification hereunder, the person or
persons or entity making such determination shall presume that Indemnitee is entitled to indemnification under this Agreement. Anyone seeking to overcome this presumption shall have the burden of proof and the burden of persuasion, by clear and
convincing evidence. 
 (e) Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is based on the records or
books of account of the Enterprise (as defined below), including financial statements, or on information supplied to an Indemnitee by the directors, officers, agents or employees of the Enterprise in the course of their duties, or on the advice of
legal counsel for the Enterprise or on information or records given or reports made to the Enterprise by an independent certified public accountant or by an appraiser or other expert selected by the Enterprise. In addition, the knowledge and/or
actions, or failure to act, of any director, officer, agent or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement. Whether or not the foregoing provisions of
this Section 6(e) are satisfied, it shall in any event be presumed that Indemnitee has at all times acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company. Anyone seeking
to overcome this presumption shall have the burden of proof and the burden of persuasion, by clear and convincing evidence. 
 (f) If the
person, persons or entity empowered or selected under Section 6 to determine whether Indemnitee is entitled to indemnification shall not have made a determination within thirty (30) days after receipt by the Company of the request
therefor, the requisite determination of entitlement to indemnification shall be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a
material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) such indemnification is expressly prohibited under applicable law; provided, however, that such
thirty (30) day period may be extended for a reasonable time, not to exceed an additional fifteen (15) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires
such additional time to obtain or evaluate documentation and/or information relating thereto; and provided, further, that the foregoing provisions of this Section 6(f) shall not apply if the determination of entitlement to indemnification is to
be made by the stockholders pursuant to Section 6(b) of this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for such determination the Board of Directors or the Disinterested Directors, if
appropriate, resolve to submit such determination to the stockholders 

  
 Page 6 

 
for their consideration at an annual meeting thereof to be held within seventy-five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of
stockholders is called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such determination is made
thereat. 
 (g) Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee’s
entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available
to Indemnitee and reasonably necessary to such determination. Any Independent Counsel, member of the Board of Directors, or stockholder of the Company shall act reasonably and in good faith in making a determination of Indemnitee’s entitlement
to indemnification under this Agreement. Any costs or expenses (including attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company
(irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom. 

(h) The Company acknowledges that a settlement or other disposition short of final judgment may be successful if it permits a party to avoid
expense, delay, distraction, disruption and uncertainty. In the event that any action, claim or proceeding to which Indemnitee is a party is resolved in any manner other than by adverse judgment against Indemnitee (including, without limitation,
settlement of such action, claim or proceeding with or without payment of money or other consideration) it shall be presumed that Indemnitee has been successful on the merits or otherwise in such action, suit or proceeding. Anyone seeking to
overcome this presumption shall have the burden of proof and the burden of persuasion, by clear and convincing evidence. 
 (i) The
termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself
adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the Company or, with respect
to any criminal Proceeding, that Indemnitee had reasonable cause to believe that Indemnitee’s conduct was unlawful. 
 (j) The Company
shall not enter into any settlement of any action, suit or proceeding in which Indemnitee is or could reasonably become a party unless such settlement provides for a full and final release of all claims asserted against Indemnitee. 

7. Remedies of Indemnitee. 
 (a) In the
event that (i) a determination is made pursuant to Section 6 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 5 of this
Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 6(b) of this Agreement within ninety (90) days after receipt by the Company of the request for

  
 Page 7 

 
indemnification, (iv) payment of indemnification is not made pursuant to this Agreement within ten (10) days after receipt by the Company of a written request therefor, (v) no
contribution has been timely made pursuant to Section 3 hereof or (vi) payment of indemnification is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification or such
determination is deemed to have been made pursuant to Section 6 of this Agreement, Indemnitee shall be entitled to an adjudication in an appropriate court of the State of Delaware, or in any other court of competent jurisdiction, of
Indemnitee’s entitlement to such indemnification. The Company shall not oppose Indemnitee’s right to seek any such adjudication. 

(b) In the event that a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is not entitled to
indemnification, any judicial proceeding commenced pursuant to this Section 7 shall be conducted in all respects as a de novo trial, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination under
Section 6(b). 
 (c) If a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is entitled
to indemnification, the Company shall be bound by such determination in any judicial proceeding commenced pursuant to this Section 7, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary
to make Indemnitee’s misstatement not misleading, in connection with Indemnitee’s request for indemnification, or (ii) a prohibition of such indemnification under applicable law. 

(d) In the event that Indemnitee, pursuant to this Section 7, seeks a judicial adjudication of Indemnitee’s rights under, or to
recover damages for breach of, this Agreement, or to recover under any D&O Insurance maintained by the Company, the Company shall pay on Indemnitee’s behalf, in advance, any and all expenses (of the types described in the definition of
Expenses in Section 15 of this Agreement) incurred or paid by Indemnitee in such judicial adjudication, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement of expenses or insurance
recovery. The Company shall, within ten (10) days after receipt by the Company of a written request therefor from Indemnitee, advance such Expenses to Indemnitee pursuant to comparable procedures as those set forth in Section 5 with
respect to advancement of Expenses therein. 
 (e) The Company shall be precluded from asserting in any judicial proceeding commenced
pursuant to this Section 7 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court that the Company is bound by all the provisions of this Agreement. The Company shall
indemnify Indemnitee against any and all Expenses and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefore) advance, to the extent not prohibited by law, such Expenses to
Indemnitee, which are incurred by Indemnitee in connection with any action brought by Indemnitee for indemnification or advance of Expenses from the Company under this Agreement or under any D&O Insurance maintained by the Company, regardless of
whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement of Expenses or insurance recovery, as the case may be. 

  
 Page 8 

 8. Non-Exclusivity; Survival of Rights; Insurance;
Subrogation. 
 (a) The rights of indemnification as provided by this Agreement shall not be deemed exclusive of any other rights to
which Indemnitee may at any time be entitled under applicable law, the certificate of incorporation of the Company, the Bylaws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. No amendment, alteration or repeal of
this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by Indemnitee in Indemnitee’s Corporate Status prior to such amendment, alteration or
repeal. To the extent that a change in the Law, whether by statute or judicial decision, permits greater indemnification than would be afforded currently under the Bylaws and this Agreement, Indemnitee shall enjoy by this Agreement the greater
benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder
or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy. 

(b) Indemnitee shall be covered by the D&O Insurance and any other insurance policy or policies providing liability insurance for
directors, officers, employees, or agents or fiduciaries of the Company or of any other Enterprise, and Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for
any such director, officer, employee, agent or fiduciary under such policy or policies. At the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company shall give prompt notice of the commencement of such proceeding to
the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such
proceeding in accordance with the terms of such policies. Further, if requested by Indemnitee, within two (2) business days of such request, the Company will instruct the insurers and their insurance brokers that they may communicate directly
with Indemnitee regarding such claim. 
 [(c) The Company hereby acknowledges that Indemnitee has certain rights to indemnification,
advancement of expenses and/or insurance provided by the Fund Indemnitors. The Company hereby agrees (i) that it is the indemnitor of first resort (i.e., its obligations to Indemnitee are primary and any obligation of the Fund Indemnitors to
advance expenses or to provide indemnification for the same expenses or liabilities incurred by Indemnitee are secondary), (ii) that it shall be required to advance the full amount of Expenses incurred by Indemnitee and shall be liable for the full
amount of all Expenses and Liabilities to the extent legally permitted and as required by the terms of this Agreement and the Certificate of Incorporation or Bylaws of the Company (or any other agreement between the Company and Indemnitee), without
regard to any rights Indemnitee may have against the Fund Indemnitors, and, (iii) that it irrevocably waives, relinquishes and releases the Fund Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation or
any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by the Fund Indemnitors on behalf of Indemnitee with respect to any claim for which Indemnitee has sought indemnification from the Company
shall affect the foregoing and the Fund Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of Indemnitee against the Company. The Company and Indemnitee
agree that the Fund Indemnitors are express third party beneficiaries of the terms hereof.] 

  
 Page 9 

 (d) In the event of a change of control or the Company’s becoming insolvent, the
Company shall maintain in force any and all insurance policies then maintained by the Company in providing insurance—directors’ and officers’ liability, fiduciary, employment practices or
otherwise--in respect of the individual directors and officers of the Company, for a fixed period of six (6) years thereafter (a “Tail Policy”). Such coverage shall be non-cancellable and shall be placed and serviced for the duration of its term by the Company’s incumbent insurance broker or a broker of at least substantially comparable standing and reputation as determined
by the Company. Such broker shall place the Tail Policy with the incumbent insurance carriers using the policies that were in place at the time of the change of control event (unless the incumbent carriers will not offer such policies, in which case
the Tail Policy placed by the Company’s insurance broker shall be substantially comparable in scope and amount as the expiring policies, and the insurance carriers for the Tail Policy shall have an AM Best rating that is the same or better than
the AM Best ratings of the expiring policies). 
 (e) [Except as provided in paragraph (c) above, ]in the event of any payment under
this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee (other than against Fund Indemnitors), who shall execute all papers required and take all action necessary to secure such
rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights. 
 (f) [Except as
provided in paragraph (c) above, ]the Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any
insurance policy, contract, agreement or otherwise; provided, however, that payment made to Indemnitee pursuant to an insurance policy purchased and maintained by Indemnitee at his or her own expense of any amounts otherwise indemnifiable or
obligated to be made pursuant to this Agreement shall not reduce the Company’s obligations to Indemnitee pursuant to this Agreement. The Company is intended to be the primary source of payment of amounts indemnifiable hereunder, and any
personal policy shall be considered a secondary source, it being understood that Indemnitee is not entitled to recover for the same amounts with respect to the same claim(s) from both the Company and a personal policy, but may recover an additional
amount from a personal policy in excess of the amount of the payment(s) made by the Company in respect of the same claim(s) (e.g., if the total liability for a claim is $2,000,000, and the Company pays $1,500,000 of such liability, then Indemnitee
may recover an additional $500,000 from a personal policy). For the avoidance of doubt, any payment(s) received by Indemnitee from the Company after a payment from a personal policy shall be used to reimburse the personal insurance provider to the
extent such any payment(s) relate to the same amounts for the same claim(s), and are not additional coverage as contemplated in the preceding sentence. 

(g) [Except as provided in paragraph (c) above, ]the Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee
who is or was serving at the request of the Company as a director, officer, employee, agent or fiduciary of any other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such
other Enterprise. 

  
 Page 10 

 9. Exception to Right of Indemnification. Notwithstanding any other provision of this
Agreement, Indemnitee shall not be entitled to indemnification under this Agreement with respect to: 
 (a) any claim made against Indemnitee
for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of
state statutory law or common law; or 
 (b) any Proceeding brought by Indemnitee, or any claim therein, unless (i) the bringing of such
Proceeding or making of such claim shall have been approved by the Board of Directors, (ii) such Proceeding is being brought by Indemnitee to assert, interpret or enforce Indemnitee’s rights under this Agreement, or (iii) the Company
provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law. 
 10. Duration
of Agreement. All agreements and obligations of the Company contained herein shall continue during the period Indemnitee is an officer or director of the Company (and, to the extent applicable, is serving at the request of the Company as a
director, officer, employee, agent or fiduciary of any other Enterprise) and shall continue thereafter so long as Indemnitee shall be subject to any Proceeding (or any proceeding commenced under Section 7 hereof) by reason of Indemnitee’s
Corporate Status, whether or not Indemnitee is acting or serving in any such capacity at the time any Liability or Expense is incurred for which indemnification can be provided under this Agreement. This Agreement shall be binding upon and inure to
the benefit of and be enforceable by the parties hereto and their respective successors (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the
Company), assigns, spouses, heirs, executors and personal and legal representatives. In addition, the Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially
all, or a substantial part, of the business and/or assets of the Company, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement and indemnify Indemnitee to the fullest extent
permitted by law. 
 11. Security. To the extent requested by Indemnitee and approved by the Board of Directors, the Company may at
any time and from time to time provide security to Indemnitee for the Company’s obligations hereunder through an irrevocable bank line of credit, funded trust or other collateral. Any such security, once provided to Indemnitee, may not be
revoked or released without the prior written consent of Indemnitee. 
 12. Enforcement. 

(a) The Company expressly confirms and agrees that it has entered into this Agreement and assumes the obligations imposed on it hereby in order
to induce Indemnitee to serve as an officer or director of the Company (and, to the extent applicable, as a director, officer, employee, agent or fiduciary of any other Enterprise), and the Company acknowledges that Indemnitee is relying upon this
Agreement in serving as an officer or director of the Company (and, to the extent applicable, as a director, officer, employee, agent or fiduciary of any other Enterprise). 

  
 Page 11 

 (b) This Agreement constitutes the entire agreement between the parties hereto with respect
to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof[, other than other rights to Indemnification held by the Fund
Indemnitors, which shall continue in full force and effect in addition to the rights of Indemnification provided hereunder]. 
 13.
Monetary Damages Insufficient; Specific Performance. The Company and Indemnitee agree that a monetary remedy for breach of this Agreement may be inadequate, impracticable and difficult of proof, and further agree that such breach may cause
Indemnitee irreparable harm. Accordingly, the parties hereto agree that Indemnitee may enforce this Agreement by seeking injunctive relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm (having
agreed that actual and irreparable harm will result in not forcing the Company to specifically perform its obligations pursuant to this Agreement) and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be precluded
from seeking or obtaining any other relief to which he may be entitled. The Company and Indemnitee further agree that Indemnitee shall be entitled to such specific performance and injunctive relief, including temporary restraining orders,
preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a waiver, a bond or undertaking may be required of Indemnitee by
the Court, and the Company hereby waives any such requirement of a bond or undertaking. If Indemnitee seeks mandatory injunctive relief, it shall not be a defense to enforcement of the Company’s obligations set forth in this Agreement that
Indemnitee has an adequate remedy at law for damages. 
 14. Information Sharing. In the event Indemnitee is the subject of or is
implicated in any way during an investigation, whether formal or informal, the Company, if deemed legally permissible and appropriate by the Company, upon advice of counsel, shall promptly notify Indemnitee of such investigation. Further, to the
extent deemed legally permissible and appropriate by the Company, upon advice of counsel, the Company shall further share with Indemnitee any information it has turned over to any third parties concerning the investigation (“Shared
Information”) at the time such information is so furnished. By executing this agreement, Indemnitee agrees that such Shared Information is material non-public information that Indemnitee is obligated to
hold in confidence and may not disclose publicly; provided, however, that Indemnitee is permitted to use the Shared Information and to disclose such Shared information to Indemnitee’s legal counsel and third parties solely in connection with
defending Indemnitee from legal liability. 
 15. Definitions. For purposes of this Agreement: 

(a) “Corporate Status” describes the status of a person or entity who is or was a director, officer, employee, agent,
equityholder, consultant, or fiduciary of the Company or is or was a director, officer, employee, agent or fiduciary of any other Enterprise. 

(b) “Disinterested Director” means a director of the Company who is not and was not a party to the Proceeding in
respect of which indemnification is sought by Indemnitee. 

  
 Page 12 

 (c) “Enterprise” shall mean the Company and any other corporation,
partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, employee, agent or fiduciary. 

(d) “Expenses” shall include all reasonable attorneys’ fees, retainers, court costs, transcript costs, fees of
experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other disbursements or expenses of the types customarily incurred in connection with prosecuting,
defending, preparing to prosecute or defend, investigating, participating, or being or preparing to be a witness in a Proceeding. Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding, including
without limitation the premium, security for, and other costs relating to any cost bond, supersede as bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of
judgments or fines against Indemnitee. 
 (e) “Independent Counsel” means a law firm, or a member of a law firm, that
is experienced in matters of corporation law and neither presently is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters
concerning Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the
term “Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to
determine Indemnitee’s rights under this Agreement. The Company agrees to pay the reasonable fees of the Independent Counsel referred to above and to fully indemnify such counsel against any and all Expenses and Liabilities arising out of or
relating to this Agreement or its engagement pursuant hereto. 
 (f) “Liabilities” includes judgments, penalties,
fines, interest, assessments, charges and amounts paid in settlement. 
 (g) “Proceeding” includes any threatened,
pending or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation (whether formal or informal), inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought by or in the
right of the Company or otherwise and whether civil, criminal, administrative or investigative, in which Indemnitee was, is or will be involved as a party or otherwise, by reason of the fact that Indemnitee invested in the Company, Indemnitee
facilitated or managed any investment in the Company, Indemnitee is or was a director or officer of the Company, by reason of any action taken by Indemnitee or of any inaction on Indemnitee’s part while acting as an officer or director of the
Company, or by reason of the fact that Indemnitee is or was serving at the request of the Company as a director, officer, employee, agent or fiduciary of any other Enterprise; in each case whether or not Indemnitee is acting or serving in any such
capacity at the time any Liability or Expense is incurred for which indemnification can be provided under this Agreement; including one pending on or before the date of this Agreement; and excluding one initiated by an Indemnitee pursuant to
Section 7 of this Agreement to enforce Indemnitee’s rights under this Agreement. 

  
 Page 13 

 16. Severability. If any provision or provisions of this Agreement shall be held by a
court of competent jurisdiction to be invalid, void, illegal or otherwise unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each
portion of any section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain
enforceable to the fullest extent permitted by law; and (b) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any section of this Agreement containing any such provision held to be
invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby. 

17. Modification and Waiver. No supplement, modification, termination or amendment of this Agreement shall be binding unless executed in
writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.

 18. Notice By Indemnitee. Indemnitee agrees promptly to notify the Company upon being served with any summons, citation, subpoena,
complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification covered hereunder. The failure to notify the Company shall not relieve the Company of any obligation which it may have
to Indemnitee under this Agreement or otherwise unless and only to the extent that such failure or delay materially prejudices the Company. 

19. Notices. All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly
given (i) upon delivery, when delivered personally or by overnight courier, (ii) when sent, if sent by email or fax during the recipient’s normal business hours, and if not sent during normal business hours, then on the
recipient’s next business day, or (iii) 48 hours after being deposited in the U.S. mail, with postage prepaid, addressed to the party to be notified at such party’s address: 

(a) If to Indemnitee, to the address set forth below Indemnitee’s signature hereto. 

(b) If to the Company, to: 

Procore Technologies, Inc. 
 6309
Carpinteria Avenue 
 Carpinteria, CA 93103 

Attention: Chief Legal Officer 

Email: legalnotice@procore.com 
 or to such other
address as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case may be. 
 20. Identical
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by
the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement. 

  
 Page 14 

 21. Headings. The headings of the paragraphs of this Agreement are inserted for
convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof. 
 22. Governing
Law. The parties agree that this Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware without application of the conflict of laws principles thereof. Any reference made in this
Agreement to a judicial determination, decision or action of the Court of Chancery of the State of Delaware or another court of competent jurisdiction shall mean a final, non-appealable order. 

23. Gender. Use of the masculine pronoun shall be deemed to include usage of the feminine and gender-neutral pronoun where appropriate.

 [Signature Page Follows] 

  
 Page 15 

 IN WITNESS WHEREOF, the
parties hereto have executed this Agreement on and as of the day and year first above written. 
  

			
	COMPANY (ON BEHALF OF ITSELF AND, WITH RESPECT TO
SECTION 1(D), ITS SUBSIDIARIES):
	
	PROCORE TECHNOLOGIES, INC.
		
	BY:	 	
         

					
	NAME: CRAIG F. COURTEMANCHE, JR.
	TITLE: PRESIDENT AND CHIEF EXECUTIVE OFFICER

			
		
	INDEMNITEE	 	

 
			
		
	SIGNATURE:	 	  

 
			
	NAME: 	 	  

 
			
	ADDRESS:	 	  

 
			
	  

			
	EMAIL:	 	  

 Signature Page to Indemnification Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}]]